| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2021 | Bejanyan N, Vlasova-St Louis I, Mohei H, Cao Q, El Jurdi N, Wagner JE, Miller JS, Brunstein CG. Cytomegalovirus-Specific Immunity Recovers More Slowly after Cord Blood Transplantation Compared with Matched Sibling Donor Allogeneic Transplantation. Transplantation and Cellular Therapy. 27: 187.e1-187.e4. PMID 33718897 DOI: 10.1016/j.jtct.2020.11.014 | 0.351 | |||
| 2021 | Okoev G, Weisdorf DJ, Wagner JE, Blazar BR, MacMillan ML, DeFor T, Lazaryan A, El Jurdi N, Holtan SG, Brunstein CG, Betts BC, Takahashi T, Bachanova V, Warlick ED, Rashidi A, et al. Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant. Bone Marrow Transplantation. PMID 33420387 DOI: 10.1038/s41409-020-01195-5 | 0.315 | |||
| 2021 | Bi X, Carabasi M, Filicko-Ohara J, Klumpp T, Wagner J, Gergis U, Flomenberg N, Grosso D. The Two-Step Haploidentical Allogeneic Stem Cell Transplant Approach Results in Rapid Engraftment and Excellent Outcomes in Patients ≥70 Years Old Transplantation and Cellular Therapy. 27: S436. DOI: 10.1016/S2666-6367(21)00563-7 | 0.318 | |||
| 2021 | Yang Y, Gergis U, Carabasi M, Filicko-O’Hara J, Wagner J, O’Hara WJ, Binder A, Alpdogan O, Martinez-Outschoorn U, Porcu P, Flomenberg N, Grosso D. The Two-Step Allogeneic Stem Cell Transplant Approach Results in Rapid Engraftment and Excellent Outcomes in Patients with Lymphoid Malignancies Transplantation and Cellular Therapy. 27: S419. DOI: 10.1016/S2666-6367(21)00539-X | 0.321 | |||
| 2021 | Ferdjallah A, Long S, Defor TE, Hoffmann C, Wagner JE, Jacobson P, MacMillan ML. CYP2B6 Variants in Cyclophosphamide Metabolism and the Incidence of Hemorrhagic Cystitis in Fanconi Anemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation Transplantation and Cellular Therapy. 27: S219. DOI: 10.1016/S2666-6367(21)00270-0 | 0.326 | |||
| 2020 | Gupta AO, Wagner JE. Umbilical Cord Blood Transplants: Current Status and Evolving Therapies. Frontiers in Pediatrics. 8: 570282. PMID 33123504 DOI: 10.3389/fped.2020.570282 | 0.363 | |||
| 2020 | El Jurdi N, Rogosheske J, DeFor T, Bejanyan N, Arora M, Bachanova V, Betts B, He F, Holtan S, Janakiram M, Larson S, Maakaron J, Rashidi A, Warlick E, Wagner JE, et al. Prophylactic foscarnet for human herpesvirus 6: effect on hematopoietic engraftment after reduced intensity conditioning umbilical cord blood transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 33053448 DOI: 10.1016/j.bbmt.2020.10.008 | 0.319 | |||
| 2020 | Brazauskas R, Scigliuolo GM, Wang HL, Cappelli B, Ruggeri AL, Fitzhugh CD, Hankins JS, Kanter J, Meerpohl JJ, Panepinto JA, Rondelli D, Shenoy S, Walters MC, Wagner JE, Tisdale JF, et al. Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease. Blood. PMID 32518950 DOI: 10.1182/blood.2020005687 | 0.301 | |||
| 2020 | Wagner JE, Ballen KK, Zhang M, Johnson MH, Karanas C, Milano F, Verneris MR, Eapen M. Comparison of Haploidentical Related Donor with Post-Transplant Cyclophosphamide (PTCy) and Umbilical Cord Blood (UCB) Transplantation after Myeloablative Conditioning for Hematological Malignancy Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.566 | 0.379 | |||
| 2020 | Wagner JE, Brunstein CG, McKenna DH, Sumstad D, Miller JS, Blazar BR, Defor TE, Boitano AE, Cooke MP, Raffel GD, Davis JC, Stefanski H. Mgta-456, a Cell Therapy Utilizing Expansion of CD34+ Hematopoietic Stem Cells (HSC), Improves HLA Matching for Adult Recipients, Promotes Faster Hematopoietic Recovery and Enables Uniform Engraftment with Less Acute Graft-Vs-Host Disease (GVHD) Biology of Blood and Marrow Transplantation. 26: S205-S206. DOI: 10.1016/J.Bbmt.2019.12.222 | 0.328 | |||
| 2019 | Hussein E, DeFor T, Wagner JE, Sumstad D, Brunstein CG, McKenna DH. Evaluation of post-thaw CFU-GM: clinical utility and role in quality assessment of umbilical cord blood in patients receiving single unit transplant. Transfusion. PMID 31756003 DOI: 10.1111/trf.15592 | 0.316 | |||
| 2019 | Eapen M, Brazauskas R, Walters MC, Bernaudin F, Bo-Subait K, Fitzhugh CD, Hankins JS, Kanter J, Meerpohl JJ, Bolaños-Meade J, Panepinto JA, Rondelli D, Shenoy S, Williamson J, Woolford TL, ... ... Wagner JE, et al. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study. The Lancet. Haematology. PMID 31495699 DOI: 10.1016/S2352-3026(19)30154-1 | 0.352 | |||
| 2019 | Holtan SG, Zhang L, DeFor TE, Bejanyan N, Arora M, Rashidi A, Lazaryan A, Kotiso F, Blazar BR, Wagner JE, Brunstein CG, MacMillan ML, Weisdorf DJ. Dynamic graft-versus-host disease-free, relapse-free survival (dGRFS): Multistate modeling of the morbidity and mortality of allotransplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31128328 DOI: 10.1016/J.Bbmt.2019.05.015 | 0.307 | |||
| 2019 | Perales MA, Tomlinson B, Zhang MJ, St Martin A, Beitinjaneh A, Gibson J, Hogan W, Kekre N, Lazarus H, Marks D, McGuirk J, Romee R, Solh M, Wagner JE, Weisdorf DJ, et al. Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical Donor? Haematologica. PMID 31101756 DOI: 10.3324/haematol.2018.215202 | 0.366 | |||
| 2019 | Mayani H, Wagner JE, Broxmeyer HE. Cord blood research, banking, and transplantation: achievements, challenges, and perspectives. Bone Marrow Transplantation. PMID 31089283 DOI: 10.1038/S41409-019-0546-9 | 0.363 | |||
| 2019 | Wagner JE. Cord blood 2.0: state of the art and future directions in transplant medicine. Blood Research. 54: 7-9. PMID 30956957 DOI: 10.5045/br.2019.54.1.7 | 0.307 | |||
| 2019 | Keating AK, Langenhorst J, Wagner JE, Page KM, Veys P, Wynn RF, Stefanski H, Elfeky R, Giller R, Mitchell R, Milano F, O'Brien TA, Dahlberg A, Delaney C, Kurtzberg J, et al. The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia. Blood Advances. 3: 1118-1128. PMID 30952678 DOI: 10.1182/bloodadvances.2018025908 | 0.392 | |||
| 2019 | Ebens CL, McGrath JA, Tamai K, Hovnanian A, Wagner JE, Riddle MJ, Keene DR, DeFor TE, Tryon R, Chen M, Woodley DT, Hook K, Tolar J. Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of non-hematopoietic cellular grafts. The British Journal of Dermatology. PMID 30843184 DOI: 10.1111/bjd.17858 | 0.313 | |||
| 2019 | Turcotte LM, Cao Q, Cooley SA, Curtsinger J, Holtan SG, Luo X, Yingst A, Weisdorf DJ, Blazar BR, Miller JS, Wagner JE, Verneris MR. Monocyte subpopulation recovery as predictors of hematopoietic cell transplantation outcomes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30625388 DOI: 10.1016/J.Bbmt.2019.01.003 | 0.333 | |||
| 2019 | Okoev G, Weisdorf DJ, Wagner JE, Blazar BR, MacMillan ML, DeFor TE, Lazaryan A, El Jurdi NH, Holtan S, Brunstein CG, Betts BC, Takahashi T, Bachanova V, Warlick ED, Rashidi A, et al. Outcomes of Chronic Graft-Versus-Host Disease (cGVHD) Following Matched Sibling Donor (MSD) Versus Umbilical Cord Blood Transplant (UCBT) Blood. 134: 2009-2009. DOI: 10.1182/Blood-2019-123421 | 0.308 | |||
| 2019 | Stefanski H, Brunstein CG, McKenna DH, Sumstad D, Miller JS, Blazar BR, DeFor TE, Boitano AE, Cooke MP, Raffel GD, Davis JC, Wagner JE. Mgta-456, an Aryl Hydrocarbon Receptor (AHR) Antagonist Based Expansion of CD34+ Hematopoietic Stem Cells (HSC), Permits Selection of Better HLA Matched Cord Blood Units (CBUs) and Promotes Faster Neutrophil Recovery and Uniform Engraftment with Potentially Less Acute Graft-Vs-Host Disease (GVHD) Blood. 134: 804-804. DOI: 10.1182/Blood-2019-122329 | 0.332 | |||
| 2019 | Orchard PJ, Raffel GD, Condon CEH, Monaghan CA, Braun JA, Shanley R, Lund TC, Gupta A, Boitano AE, Cooke M, Davis DC, Wagner JE. Preliminary results demonstrate engraftment with minimal neutropenia with MGTA-456, a CD34+expanded cord blood (CB) product in patients transplanted for inherited metabolic disorders (IMD) Molecular Genetics and Metabolism. 126. DOI: 10.1016/J.Ymgme.2018.12.286 | 0.33 | |||
| 2019 | Orchard PJ, Raffel GD, Condon CE, Monaghan CA, Braun JA, Shanley R, Lund TC, Gupta A, Boitano AE, Cooke MP, Davis JC, Wagner JE. Robust Engraftment with Mgta-456, a CD34+ Expanded Cell Therapy Product in Patients with Inherited Metabolic Disorders (IMD): Preliminary Phase 2 Trial Results Biology of Blood and Marrow Transplantation. 25. DOI: 10.1016/J.Bbmt.2018.12.171 | 0.336 | |||
| 2018 | Horwitz ME, Wease S, Blackwell B, Valcarcel D, Frassoni F, Boelens JJ, Nierkens S, Jagasia M, Wagner JE, Kuball J, Koh LP, Majhail NS, Stiff PJ, Hanna R, Hwang WYK, et al. Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1800053. PMID 30523748 DOI: 10.1200/JCO.18.00053 | 0.367 | |||
| 2018 | Bejanyan N, Brunstein CG, Cao Q, Lazaryan A, Luo X, Curtsinger J, Mehta RS, Warlick E, Cooley SA, Blazar BR, Miller JS, Weisdorf D, Wagner JE, Verneris MR. Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD. Blood Advances. 2: 909-922. PMID 29678809 DOI: 10.1182/Bloodadvances.2017014464 | 0.324 | |||
| 2018 | Orchard P, Raffel GD, Condon CH, Monaghan CA, Vernet D, Sheirr ST, Braun J, Shanley R, Lund TC, Boitano AE, Cooke MP, Davis JC, Wagner JE. Preliminary Phase 2 Results Demonstrate Engraftment with Minimal Neutropenia with MGTA-456, a CD34+ Expanded Cord Blood (CB) Product in Patients Transplanted for Inherited Metabolic Disorders (IMD) Blood. 132: 3467-3467. DOI: 10.1182/Blood-2018-99-115102 | 0.329 | |||
| 2018 | Garcia Garcia J, Grillo S, Cao Q, Brunstein CG, Arora M, MacMillan ML, Wagner JE, Weisdorf DJ, Holtan SG. 5 Year Health Care Burden after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Impact of Graft Source Blood. 132: 367-367. DOI: 10.1182/BLOOD-2018-99-113201 | 0.324 | |||
| 2018 | Ebens CL, McGrath JA, Tamai K, Alain H, Wagner JE, Riddle M, Keene DR, DeFor TE, Tryon R, Chen M, Woodley DT, Hook K, Tolar JL. Reduced Intensity Conditioned Bone Marrow Transplant with Post-Transplant Cyclophosphamide and Donor-Derived Mesenchymal Stromal Cell Infusions for Recessive Dystrophic Epidermolysis Bullosa Blood. 132: 2165-2165. DOI: 10.1182/BLOOD-2018-99-113035 | 0.346 | |||
| 2018 | Bejanyan N, Rogosheske J, Cao Q, Lazaryan A, Holtan SG, Ustun C, Jacobson P, MacMillan ML, Weisdorf DJ, Wagner JE, Arora M, Brunstein CG. Weight-Based Mycophenolate Mofetil Dosing Predicts Acute Gvhd and Relapse after Allogeneic Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation. 24: S291. DOI: 10.1016/J.BBMT.2017.12.330 | 0.302 | |||
| 2018 | Keating AK, Langenhorst J, Wagner JE, Page K, Veys P, Wynn RF, Stefanski H, Elfeky R, Giller R, Mitchell R, Milano F, O'Brien TA, Dahlberg A, Delaney C, Kurtzberg J, et al. The Influence of Stem Cell Source on Chronic-GvHD Free, Leukemia Free Transplant Survival in Pediatric Patients with Acute Myeloid Leukemia Biology of Blood and Marrow Transplantation. 24: S113-S114. DOI: 10.1016/J.BBMT.2017.12.029 | 0.305 | |||
| 2017 | Ebens CL, DeFor TE, Tryon R, Wagner JE, MacMillan ML. Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29203412 DOI: 10.1016/j.bbmt.2017.11.031 | 0.318 | |||
| 2017 | Dietz AC, Savage SA, Vlachos A, Mehta PA, Bresters D, Tolar J, Bonfim C, Dalle JH, de la Fuente J, Skinner R, Boulad F, Duncan CN, Baker KS, Pulsipher MA, Lipton JM, ... Wagner JE, et al. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Inherited Bone Marrow Failure Syndromes (IBMFS): Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28533057 DOI: 10.1016/j.bbmt.2017.05.022 | 0.355 | |||
| 2017 | Barker JN, Kurtzberg J, Ballen K, Boo M, Brunstein C, Cutler C, Horwitz M, Milano F, Olson A, Spellman S, Wagner JE, Delaney C, Shpall E. Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28279825 DOI: 10.1016/j.bbmt.2017.03.006 | 0.386 | |||
| 2017 | Mitchell R, Wagner JE, Brunstein C, Cao Q, McKenna DH, Verneris MR. The Impact of Delayed Infusion Time in Umbilical Cord Blood Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28214595 DOI: 10.1016/j.bbmt.2017.02.010 | 0.355 | |||
| 2017 | Dietz AC, Mehta PA, Vlachos A, Savage SA, Bresters D, Tolar J, Boulad F, Dalle JH, Bonfim C, de la Fuente J, Duncan CN, Baker KS, Pulsipher MA, Lipton JM, Wagner JE, et al. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation (HCT) for Inherited Bone Marrow Failure Syndromes (IBMFS): Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28115275 DOI: 10.1016/j.bbmt.2017.01.075 | 0.34 | |||
| 2016 | Ebens CL, MacMillan ML, Wagner JE. Hematopoietic cell transplantation in Fanconi Anemia: Current evidence, challenges and recommendations. Expert Review of Hematology. PMID 27929686 DOI: 10.1080/17474086.2016.1268048 | 0.351 | |||
| 2016 | McKenna DH, Sumstad D, Kadidlo DM, Batdorf B, Lord CJ, Merkel SC, Koellner CM, Curtsinger JM, June CH, Riley JL, Levine BL, Miller JS, Brunstein CG, Wagner JE, Blazar BR, et al. Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trials. Cytotherapy. PMID 27887864 DOI: 10.1016/J.Jcyt.2016.10.011 | 0.331 | |||
| 2016 | Dietz AC, Duncan CN, Alter BP, Bresters D, Cowan MJ, Notarangelo L, Rosenberg PS, Shenoy S, Skinner R, Walters MC, Wagner J, Baker KS, Pulsipher MA. The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation (HCT): Defining the Unique Late Effects of Children Undergoing HCT for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27737772 DOI: 10.1016/J.Bbmt.2016.10.004 | 0.346 | |||
| 2016 | Bejanyan N, Rogosheske J, DeFor TE, Lazaryan A, Arora M, Holtan SG, Jacobson PA, MacMillan ML, Verneris MR, Blazar BR, Weisdorf DJ, Wagner JE, Brunstein CG. Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free GVHD Prophylaxis for RIC Umbilical Cord Blood Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27519278 DOI: 10.1016/J.Bbmt.2016.08.005 | 0.372 | |||
| 2016 | Eckfeldt CE, Randall N, Shanley RM, Yohe S, Bejanyan N, Dolan M, Warlick ED, Verneris MR, Brunstein CG, Wagner JE, Weisdorf DJ, Ustun C. Umbilical cord blood transplantation is a suitable option for consolidation of acute myeloid leukemia with FLT3-ITD. Haematologica. PMID 27125981 DOI: 10.3324/Haematol.2016.143628 | 0.367 | |||
| 2016 | Boull CL, Hylwa SA, Sajic D, Wagner JE, Tolar J, Hook KP. Toxic Epidermal Necrolysis in Recessive Dystrophic Epidermolysis Bullosa following Bone Marrow Transplantation. The Journal of Pediatrics. PMID 26976809 DOI: 10.1016/j.jpeds.2016.02.037 | 0.33 | |||
| 2016 | Knorr DA, Wang H, Aurora M, MacMillan ML, Holton SG, Bergerson R, Cao Q, Weisdorf DJ, Cooley S, Brunstein C, Miller JS, Wagner JE, Blazar BR, Verneris MR. Loss of T Follicular Helper Cells In the Peripheral Blood Of Patients With Chronic Graft vs. Host Disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26806586 DOI: 10.1016/J.Bbmt.2016.01.003 | 0.351 | |||
| 2016 | Barjes Alrawi E, Warlick ED, Cao Q, Arora M, Holtan SG, Krepski T, Verneris MR, Wagner J, Weisdorf DJ, Brunstein CG. High Peripheral Blood Stem Cell (PBSC) CD34+ Cell Dose Increases the Risk of Chronic Gvhd after Human Leukocyte Antigen (HLA) Matched Sibling Transplantation Blood. 128: 5877-5877. DOI: 10.1182/BLOOD.V128.22.5877.5877 | 0.3 | |||
| 2016 | Bejanyan N, Brunstein CG, Cao Q, Mehta RS, Luo X, Curtsinger J, Cooley S, Blazar BR, Miller JS, Weisdorf D, Wagner JE, Verneris MR. Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (alloHCT): Comparing Results in Recipients of Unrelated Umbilical Cord Blood (UCB) to Those with an HLA-Matched Sibling Donor Peripheral Blood (MSD PB) Blood. 128: 4590-4590. DOI: 10.1182/Blood.V128.22.4590.4590 | 0.325 | |||
| 2016 | Eapen M, Kurtzberg J, Zhang M, Mendizabal AM, Chang KW, Duval M, Fei M, Neudorf S, Oliveira SND, Wall DA, Schultz KR, Horowitz MM, Wagner JE. Umbilical Cord Blood (UCB) Transplantation in Children with Acute Leukemia: Impact of Conditioning Regimen on Transplant Outcomes Blood. 128: 1231-1231. DOI: 10.1182/Blood.V128.22.1231.1231 | 0.33 | |||
| 2016 | Downs E, Osborn MJ, McGrath JA, Hovnanian A, Tamai K, Wagner J, Tolar J, Baldridge AD. Mo1263 Gastrointestinal Outcomes of Recessive Dystrophic Epidermolysis Bullosa After Hematopoietic Cell Transplantation Gastroenterology. 150. DOI: 10.1016/S0016-5085(16)32322-8 | 0.308 | |||
| 2016 | Bejanyan N, Rogosheske J, Defor TE, Holtan S, Jacobson P, MacMillan ML, Verneris MR, Arora M, Lazaryan A, Blazar BR, Weisdorf DJ, Wagner JE, Brunstein CG. Sirolimus/Mycophenolate Mofetil (MMF): Effective Calcineurin Inhibitor-Free GVHD Prophylaxis for Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation Biology of Blood and Marrow Transplantation. 22. DOI: 10.1016/J.Bbmt.2015.11.771 | 0.324 | |||
| 2016 | Sandhu KS, Green JS, Cao Q, Lazaryan A, Ustun C, Smith AR, Weisdorf DJ, Young JH, Wagner JE, Brunstein CG, Bejanyan N. Similar Invasive Fungal Infection Rates and Survival after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Bone Marrow or Peripheral Blood Graft Sources Biology of Blood and Marrow Transplantation. 22: S174-S175. DOI: 10.1016/J.BBMT.2015.11.543 | 0.321 | |||
| 2016 | Geethakumari PR, Nair R, Alpdogan O, Carabasi M, Filicko J, Kasner M, Klumpp T, Martinez U, Sharma M, Wagner J, Weiss M, Flomenberg N, Grosso D. Increased Propensity for Relapse in Maternal Recipients of Haploidentical Hematopoietic Stem Cell Transplantation (HI HSCT): “an Evolving Donor Selection Paradigm” Biology of Blood and Marrow Transplantation. 22: S80. DOI: 10.1016/j.bbmt.2015.11.374 | 0.344 | |||
| 2016 | Wagner JE, Tolar J, Auerbach AD, MacMillan ML. Hematopoietic Cell Transplantation for Fanconi Anemia Thomas' Hematopoietic Cell Transplantation: Fifth Edition. 2: 923-946. DOI: 10.1002/9781118416426.ch76 | 0.318 | |||
| 2015 | Wagner JE, Brunstein CG, Boitano AE, DeFor TE, McKenna D, Sumstad D, Blazar BR, Tolar J, Le C, Jones J, Cooke MP, Bleul CC. Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft. Cell Stem Cell. PMID 26669897 DOI: 10.1016/J.Stem.2015.10.004 | 0.353 | |||
| 2015 | Brunstein CG, Petersdorf EW, DeFor TE, Noreen H, Maurer D, MacMillan ML, Ustun C, Verneris MR, Miller JS, Blazar BR, McGlave PB, Weisdorf DJ, Wagner JE. Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26431630 DOI: 10.1016/J.Bbmt.2015.09.025 | 0.326 | |||
| 2015 | Gaballa S, Palmisiano N, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Kraft WK, Leiby B, Martinez-Outschoorn U, O'Hara W, Pro B, Rudolph S, Sharma M, Wagner JL, Weiss M, et al. A 2-Step Haploidentical Versus A 2-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26415558 DOI: 10.1016/J.Bbmt.2015.09.017 | 0.316 | |||
| 2015 | Lazaryan A, Weisdorf DJ, DeFor T, Brunstein CG, MacMillan ML, Bejanyan N, Holtan S, Blazar BR, Wagner JE, Arora M. Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Related Donors. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26365153 DOI: 10.1016/J.Bbmt.2015.09.008 | 0.375 | |||
| 2015 | Ponce DM, Eapen M, Sparapani R, O'Brien TA, Chan KW, Chen J, Craddock J, Schultz KR, Wagner JE, Perales MA, Barker JN. In vivo T-cell depletion with myeloablative regimens on outcomes after cord blood transplantation for acute lymphoblastic leukemia in children. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26327630 DOI: 10.1016/J.Bbmt.2015.08.022 | 0.338 | |||
| 2015 | Uy GL, Costa LJ, Hari PN, Zhang MJ, Huang JX, Anderson KC, Bredeson CN, Callander NS, Cornell RF, Perez MA, Dispenzieri A, Freytes CO, Gale RP, Garfall A, Gertz MA, ... ... Wagner JL, et al. Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation. Bone Marrow Transplantation. PMID 26301967 DOI: 10.1038/bmt.2015.190 | 0.316 | |||
| 2015 | Ayas M, Eapen M, Le-Rademacher J, Carreras J, Abdel-Azim H, Alter BP, Anderlini P, Battiwalla M, Bierings M, Buchbinder DK, Bonfim C, Camitta BM, Fasth AL, Gale RP, Lee MA, ... ... Wagner JE, et al. Second allogeneic hematopoietic cell transplantation for Patients with Fanconi anemia and Bone Marrow Failure. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26116087 DOI: 10.1016/j.bbmt.2015.06.012 | 0.303 | |||
| 2015 | Davis ZB, Cooley SA, Cichocki F, Felices M, Wangen R, Luo X, DeFor TE, Bryceson YT, Diamond DJ, Brunstein C, Blazar BR, Wagner JE, Weisdorf DJ, Horowitz A, Guethlein LA, et al. Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26055301 DOI: 10.1016/J.Bbmt.2015.05.025 | 0.31 | |||
| 2015 | Cichocki F, Verneris MR, Cooley S, Bachanova V, Brunstein CG, Blazar BR, Wagner J, Schlums H, Bryceson YT, Weisdorf DJ, Miller JS. The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer. Current Topics in Microbiology and Immunology. PMID 26037048 DOI: 10.1007/82_2015_445 | 0.315 | |||
| 2015 | MacMillan ML, DeFor TE, Young JA, Dusenbery KE, Blazar BR, Slungaard A, Zierhut H, Weisdorf DJ, Wagner JE. Alternative donor hematopoietic cell transplantation for Fanconi anemia. Blood. 125: 3798-804. PMID 25824692 DOI: 10.1182/Blood-2015-02-626002 | 0.371 | |||
| 2015 | Bejanyan N, Rogosheske J, DeFor T, Lazaryan A, Esbaum K, Holtan S, Arora M, MacMillan ML, Weisdorf D, Jacobson P, Wagner J, Brunstein CG. Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 926-33. PMID 25655791 DOI: 10.1016/j.bbmt.2015.01.023 | 0.334 | |||
| 2015 | Wagner JE, Eapen M, Kurtzberg J. One-unit versus two-unit cord-blood transplantation. The New England Journal of Medicine. 372: 288. PMID 25587953 DOI: 10.1056/NEJMc1414419 | 0.311 | |||
| 2015 | Grosso D, Gaballa S, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Martinez-Outschoorn U, Wagner JL, O'Hara W, Rudolph S, Chervoneva I, Colombe B, Farley PC, Flomenberg P, Pro B, et al. A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 646-52. PMID 25542159 DOI: 10.1016/J.Bbmt.2014.12.019 | 0.304 | |||
| 2015 | Lund TC, Boitano AE, Delaney CS, Shpall EJ, Wagner JE. Advances in umbilical cord blood manipulation-from niche to bedside. Nature Reviews. Clinical Oncology. 12: 163-74. PMID 25511187 DOI: 10.1038/nrclinonc.2014.215 | 0.303 | |||
| 2015 | Mitchell R, Wagner JE, Brunstein CG, Cao Q, McKenna DH, Lund TC, Verneris MR. Impact of long-term cryopreservation on single umbilical cord blood transplantation outcomes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 50-4. PMID 25262882 DOI: 10.1016/j.bbmt.2014.09.002 | 0.32 | |||
| 2015 | Bejanyan N, Brunstein CG, Cao Q, Lazaryan A, Warlick ED, Ustun C, Holtan SG, Arora M, Bachanova V, Verneris MR, Wagner JE, Weisdorf DJ. Similar Survival after Umbilical Cord Blood (UCB) and HLA-Matched Adult Donor Transplantation By Disease Risk Index (DRI) Assignment Blood. 126: 4375-4375. DOI: 10.1182/BLOOD.V126.23.4375.4375 | 0.327 | |||
| 2015 | Sharma M, Gooptu M, Klumpp T, Saini N, Mandala A, Tuazon S, Nagalla S, Wagner J, Kasner M, Alpdogan O, Martinez U, Grosso D, Filicko J, Pro B, Carabasi M, et al. Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 21: S250-S251. DOI: 10.1016/j.bbmt.2014.11.393 | 0.301 | |||
| 2015 | Pathak P, Kumar SV, Alpdogan O, Carabasi M, Flomenberg N, Grosso D, Martinez-Outschoorn U, Wagner J, Weiss M, Pro B, Filicko-O'Hara J. Mantle Cell Lymphoma: Outcomes after Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 21: S202. DOI: 10.1016/J.BBMT.2014.11.309 | 0.308 | |||
| 2015 | Phelan R, Mann E, Napurski C, Defor TE, Petryk A, Miller WP, Wagner JE, Verneris MR, Smith AR. Preservation of Ovarian Function after Hematopoietic Cell Transplantation (HCT): More Possible Than We Thought? Biology of Blood and Marrow Transplantation. 21: S178. DOI: 10.1016/J.BBMT.2014.11.264 | 0.317 | |||
| 2014 | Wagner JE, Eapen M, Carter S, Wang Y, Schultz KR, Wall DA, Bunin N, Delaney C, Haut P, Margolis D, Peres E, Verneris MR, Walters M, Horowitz MM, Kurtzberg J, et al. One-unit versus two-unit cord-blood transplantation for hematologic cancers. The New England Journal of Medicine. 371: 1685-94. PMID 25354103 DOI: 10.1056/NEJMoa1405584 | 0.357 | |||
| 2014 | Hagen P, Wagner JE, DeFor TE, Dolan M, Arora M, Warlick E, Weisdorf D, Brunstein CG. The effect of equine antithymocyte globulin on the outcomes of reduced intensity conditioning for AML. Bone Marrow Transplantation. 49: 1498-504. PMID 25243623 DOI: 10.1038/bmt.2014.183 | 0.379 | |||
| 2014 | Bejanyan N, Oran B, Shanley R, Warlick E, Ustun C, Vercellotti G, Verneris M, Wagner JE, Weisdorf D, Brunstein C. Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation. Bone Marrow Transplantation. 49: 1029-35. PMID 24887379 DOI: 10.1038/Bmt.2014.116 | 0.334 | |||
| 2014 | Dietz AC, DeFor TE, Brunstein CG, Wagner JE. Donor-derived myelodysplastic syndrome and acute leukaemia after allogeneic haematopoietic stem cell transplantation: incidence, natural history and treatment response. British Journal of Haematology. 166: 209-12. PMID 24661075 DOI: 10.1111/bjh.12847 | 0.304 | |||
| 2014 | Kharbanda S, Smith AR, Hutchinson SK, McKenna DH, Ball JB, Lamb LS, Agarwal R, Weinberg KI, Wagner JE. Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 581-6. PMID 24370862 DOI: 10.1016/J.Bbmt.2013.12.564 | 0.374 | |||
| 2014 | Sawitzki B, Brunstein C, Meisel C, Schumann J, Vogt K, Appelt C, Curtsinger JM, Verneris MR, Miller JS, Wagner JE, Blazar BR. Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expression. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 173-82. PMID 24184334 DOI: 10.1016/J.Bbmt.2013.10.022 | 0.311 | |||
| 2014 | Mitchell R, Wagner JE, Hirsch B, DeFor TE, Zierhut H, MacMillan ML. Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia. British Journal of Haematology. 164: 384-95. PMID 24172081 DOI: 10.1111/Bjh.12634 | 0.322 | |||
| 2014 | Ustun C, Bachanova V, Shanley R, MacMillan ML, Majhail NS, Arora M, Brunstein C, Wagner JE, Weisdorf DJ. Importance of donor ethnicity/race matching in unrelated adult and cord blood allogeneic hematopoietic cell transplant. Leukemia & Lymphoma. 55: 358-64. PMID 23647059 DOI: 10.3109/10428194.2013.800200 | 0.366 | |||
| 2014 | Wagner JE, Brunstein C, McKenna D, Sumstad D, Maahs S, Laughlin M, Perry MS, Boitano AE, Cooke MP, Bleul CC. StemRegenin-1 (SR1) Expansion Culture Abrogates the Engraftment Barrier Associated with Umbilical Cord Blood Transplantation (UCBT) Blood. 124: 728-728. DOI: 10.1182/Blood.V124.21.728.728 | 0.318 | |||
| 2014 | Ross JA, Tolar J, Spector LG, Defor TE, Lund TC, Weisdorf DJ, Hooten AJ, Thyagarajan B, Langer E, Gleason MK, Wagner JE, Robien K, Verneris MR. Mitochondrial Haplotype As an Independent Predictor of Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Blood. 124: 683-683. DOI: 10.1182/Blood.V124.21.683.683 | 0.325 | |||
| 2014 | Cichocki F, Davis ZB, DeFor TE, Cooley SA, Bryceson YT, Diamond DJ, Blazar BR, Brunstein C, Wagner JE, Verneris MR, Weisdorf DJ, Miller JS. CMV Reactivation is Associated with Reduced Relapse Risk, Better Disease-Free Survival and Expansion of Adaptive NK Cells after Reduced Intensity Hematopoietic Cell Transplantation Blood. 124: 668-668. DOI: 10.1182/Blood.V124.21.668.668 | 0.344 | |||
| 2014 | Bejanyan N, Brunstein CG, Cao Q, Thyagarajan B, Sandhu KS, Arora M, Weisdorf DJ, Wagner JE. Day 21 Chimerism Is a Critical Prognostic Factor for Graft Failure and Survival in Recipients of Myeloablative Conditioning and Umbilical Cord Blood (UCB) Transplantation Blood. 124: 3867-3867. DOI: 10.1182/Blood.V124.21.3867.3867 | 0.301 | |||
| 2014 | Lazaryan A, DeFor TE, Brunstein C, MacMillan ML, Bejanyan N, Holtan SG, Blazar BR, Wagner JE, Weisdorf DJ, Arora M. Risk Factors for Acute and Chronic Gvhd after Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Relative Risks with Umbilical Cord Blood (UCB) and Matched Related Donors (MRD) Blood. 124: 189-189. DOI: 10.1182/Blood.V124.21.189.189 | 0.358 | |||
| 2014 | Lazaryan A, Wagner JE, Brunstein CG, Defor T, MacMillan ML, Blazar BR, Weisdorf DJ, Arora M. High-Resolution Donor-Recipient HLA Matching Does Not Influence Acute or Chronic Gvhd in Umbilical Cord Blood Transplantation Biology of Blood and Marrow Transplantation. 20. DOI: 10.1016/J.Bbmt.2013.12.216 | 0.341 | |||
| 2013 | Tolar J, Wagner JE. Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix. Lancet (London, England). 382: 1214-23. PMID 24095195 DOI: 10.1016/S0140-6736(13)61897-8 | 0.331 | |||
| 2013 | Sanz J, Wagner JE, Sanz MA, DeFor T, Montesinos P, Bachanova V, Lorenzo I, Warlick E, Sanz GF, Brunstein C. Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1725-30. PMID 24090598 DOI: 10.1016/j.bbmt.2013.09.015 | 0.309 | |||
| 2013 | Locatelli F, Crotta A, Ruggeri A, Eapen M, Wagner JE, Macmillan ML, Zecca M, Kurtzberg J, Bonfim C, Vora A, DÃaz de Heredia C, Teague L, Stein J, O'Brien TA, Bittencourt H, et al. Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study. Blood. 122: 2135-41. PMID 23926304 DOI: 10.1182/blood-2013-03-491589 | 0.376 | |||
| 2013 | Burke MJ, Wagner JE, Cao Q, Ustun C, Verneris MR. Allogeneic hematopoietic cell transplantation in first remission abrogates poor outcomes associated with high-risk pediatric acute myeloid leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1021-5. PMID 23567175 DOI: 10.1016/j.bbmt.2013.04.001 | 0.301 | |||
| 2013 | Romee R, Weisdorf DJ, Brunstein C, Wagner JE, Cao Q, Blazar BR, Majhail NS, Vercellotti GM, Miller JS, Arora M. Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation. Bone Marrow Transplantation. 48: 1046-9. PMID 23419434 DOI: 10.1038/Bmt.2013.8 | 0.389 | |||
| 2013 | Duncan CN, Lehmann LE, Cheifetz IM, Greathouse K, Haight AE, Hall MW, Herschberger A, Hill KS, Moffet JR, Morrison RR, Norris AL, Petrovic A, Spear DA, Steiner ME, Talano JA, ... ... Wagner J, et al. Clinical outcomes of children receiving intensive cardiopulmonary support during hematopoietic stem cell transplant. Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 14: 261-7. PMID 23392372 DOI: 10.1097/PCC.0b013e3182720601 | 0.321 | |||
| 2013 | Scaradavou A, Brunstein CG, Eapen M, Le-Rademacher J, Barker JN, Chao N, Cutler C, Delaney C, Kan F, Isola L, Karanes C, Laughlin MJ, Wagner JE, Shpall EJ. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. Blood. 121: 752-8. PMID 23223509 DOI: 10.1182/blood-2012-08-449108 | 0.374 | |||
| 2013 | Smith AR, Christiansen EC, Wagner JE, Cao Q, MacMillan ML, Stefanski HE, Trotz BA, Burke MJ, Verneris MR. Early hematopoietic stem cell transplant is associated with favorable outcomes in children with MDS. Pediatric Blood & Cancer. 60: 705-10. PMID 23152304 DOI: 10.1002/pbc.24390 | 0.313 | |||
| 2013 | Ramirez P, Wagner JE, Defor TE, Eide CR, Miller JS, Weisdorf DJ, Brunstein CG. CXCR4 expression in CD34+ cells and unit predominance after double umbilical cord blood transplantation. Leukemia. 27: 1181-3. PMID 23060089 DOI: 10.1038/leu.2012.261 | 0.304 | |||
| 2013 | Cooley S, Curtsinger J, Shanley R, Brunstein C, Blazar BR, Wagner JE, Miller JS, Verneris MR. Early NK Cell Proliferation After Umbilical Cord Blood Transplantation Is Associated With Superior Disease-Free Survival Due To Reduced Leukemia Relapse Blood. 122: 4610-4610. DOI: 10.1182/Blood.V122.21.4610.4610 | 0.369 | |||
| 2013 | MacMillan ML, Defor TE, Wagner JE. Hematopoietic Cell Transplantation (HCT) For Fanconi Anemia (FA): Comparable Outcomes Regardless Of Stem Cell Source Blood. 122: 3706-3706. DOI: 10.1182/BLOOD.V122.21.3706.3706 | 0.369 | |||
| 2013 | Delaney C, Milano F, Nicoud I, Heimfeld S, Karanes C, Gutman JA, Wagner JE, Appelbaum FR, Bernstein ID. Dose Dependent Enhancement Of Neutrophil Recovery By Infusion Of Notch Ligand Ex Vivo Expanded Cord Blood Progenitors: Results Of a Multi-Center Phase I Trial Blood. 122: 297-297. DOI: 10.1182/blood.v122.21.297.297 | 0.358 | |||
| 2013 | Tolar J, McGrath JA, Osborn MJ, Hook KP, Keene DR, Hordinsky MK, Blazar BR, Wagner JE. Bone Marrow Is the Preferred Graft for Allogeneic Hematopoietic Cell Transplantation (HCT) in Severe Epidermolysis Bullosa Biology of Blood and Marrow Transplantation. 19. DOI: 10.1016/J.Bbmt.2012.11.135 | 0.304 | |||
| 2013 | Kurtzberg J, Carter SL, Mendizabal A, Wall DA, Schultz KR, Kernan NA, Eapen M, Wagner JE. Superior Survival After Single Unit Umbilical Cord Blood Transplantation (UCBT) in Children with Hematological Malignancies Treated on Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0501 Relative to the Cord Blood Transplantation (COBLT) Biology of Blood and Marrow Transplantation. 19: S121. DOI: 10.1016/J.BBMT.2012.11.049 | 0.352 | |||
| 2013 | Bejanyan N, Oran B, Shanley R, Ustun C, Warlick E, Verneris MR, Wagner JE, Weisdorf DJ, Brunstein CG. Similar Survival in Patients with Acute Myeloid Leukemia Relapsing After Matched Related Donor and Umbilical Cord Blood Transplantation Biology of Blood and Marrow Transplantation. 19: S113. DOI: 10.1016/J.BBMT.2012.11.034 | 0.358 | |||
| 2012 | Veys P, Wynn RF, Ahn KW, Samarasinghe S, He W, Bonney D, Craddock J, Cornish J, Davies SM, Dvorak CC, Duerst RE, Gross TG, Kapoor N, Kitko C, Krance RA, ... ... Wagner JE, et al. Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia. Blood. 119: 6155-61. PMID 22573402 DOI: 10.1182/blood-2012-01-405795 | 0.314 | |||
| 2012 | Brunstein CG, Eapen M, Ahn KW, Appelbaum FR, Ballen KK, Champlin RE, Cutler C, Kan F, Laughlin MJ, Soiffer RJ, Weisdorf DJ, Woolfrey A, Wagner JE. Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes. Blood. 119: 5591-8. PMID 22496153 DOI: 10.1182/blood-2011-12-400630 | 0.374 | |||
| 2012 | Bachanova V, Burke MJ, Yohe S, Cao Q, Sandhu K, Singleton TP, Brunstein CG, Wagner JE, Verneris MR, Weisdorf DJ. Unrelated cord blood transplantation in adult and pediatric acute lymphoblastic leukemia: effect of minimal residual disease on relapse and survival. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 963-8. PMID 22430088 DOI: 10.1016/j.bbmt.2012.02.012 | 0.337 | |||
| 2012 | Honebrink T, Dayton V, Burke MJ, Larsen K, Cao Q, Brunstein C, Weisdorf D, Miller JS, Wagner JE, Verneris MR. Impact of bone marrow hematogones on umbilical cord blood transplantation outcomes in patients with acute myeloid leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 930-6. PMID 22108570 DOI: 10.1016/j.bbmt.2011.11.015 | 0.374 | |||
| 2012 | Ramirez P, Wagner JE, DeFor TE, Blazar BR, Verneris MR, Miller JS, McKenna DH, Weisdorf DJ, McGlave PB, Brunstein CG. Factors predicting single-unit predominance after double umbilical cord blood transplantation. Bone Marrow Transplantation. 47: 799-803. PMID 21946383 DOI: 10.1038/Bmt.2011.184 | 0.324 | |||
| 2012 | Majhail NS, Brunstein CG, Shanley R, Sandhu K, McClune B, Oran B, Warlick ED, Wagner JE, Weisdorf DJ. Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors. Bone Marrow Transplantation. 47: 494-8. PMID 21602900 DOI: 10.1038/bmt.2011.114 | 0.383 | |||
| 2012 | Tolar J, McGrath JA, Osborn MJ, Hook KP, Keene DR, Hordinsky MK, Blazar BR, Wagner JE. Allogeneic Hematopoietic Cell Transplantation for Severe Epidermolysis Bullosa: Impact of Conditioning Regimen and Stem Cell Source On Outcomes Blood. 120: 965-965. DOI: 10.1182/Blood.V120.21.965.965 | 0.329 | |||
| 2012 | Wagner JE, Eapen M, Carter SL, Haut PR, Peres E, Schultz KR, Thompson J, Wall DA, Kurtzberg J. No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial Blood. 120: 359-359. DOI: 10.1182/BLOOD.V120.21.359.359 | 0.382 | |||
| 2012 | Verneris MR, Turcotte LM, Cao Q, MacMillan ML, Miller JS, Weisdorf D, Brunstein CG, Wagner JE. Increased Relapse Associated with Mixed Donor-Donor Chimerism Following Double Umbilical Cord Blood Transplantation (dUCBT) Blood. 120: 358-358. DOI: 10.1182/BLOOD.V120.21.358.358 | 0.365 | |||
| 2012 | MacMillan ML, Blazar BR, Defor TE, Dusenbery KE, Slungaard A, Verneris MR, Young JH, Zierhut H, Weisdorf DJ, Wagner JE. Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia. Blood. 120: 3081-3081. DOI: 10.1182/Blood.V120.21.3081.3081 | 0.362 | |||
| 2012 | Brunstein CG, Defor TE, Noreen H, Maurer D, MacMillan ML, Verneris MR, McGlave P, Weisdorf D, Wagner JE. Allele Level HLA Matching On Outcomes After Double Umbilical Cord Blood (dUCB) Transplantation for Hematological Malignancies: Stronger Graft Vs. Leukemia with HLA Mismatch Blood. 120: 1976-1976. DOI: 10.1182/BLOOD.V120.21.1976.1976 | 0.334 | |||
| 2012 | Lund T, Verneris M, Tolar J, Cao Q, Weisdorf D, Wagner J, Brunstein C. Encouraging Survival for Patients Who Had a Second Umbilical Cord Blood Transplant for Graft Failure Biology of Blood and Marrow Transplantation. 18: S333-S334. DOI: 10.1016/J.BBMT.2011.12.340 | 0.336 | |||
| 2012 | Hough R, Wagner JE. The Role of Bone Marrow, Peripheral Blood Stem Cells, and Cord Blood Hemopoietic Stem Cells in Autologous, Related, and Unrelated Transplants Tissue and Cell Clinical Use: An Essential Guide. 312-331. DOI: 10.1002/9781118498453.ch15 | 0.359 | |||
| 2011 | Brunstein CG, Noreen H, DeFor TE, Maurer D, Miller JS, Wagner JE. Anti-HLA antibodies in double umbilical cord blood transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 1704-8. PMID 21601639 DOI: 10.1016/j.bbmt.2011.04.013 | 0.301 | |||
| 2011 | Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatia M, Kurtzberg J, Wingard JR, Fasth A, Lo Nigro L, Ayas M, Purtill D, Boudjedir K, Chaves W, Walters MC, Wagner J, et al. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 1375-82. PMID 21277376 DOI: 10.1016/j.bbmt.2011.01.012 | 0.366 | |||
| 2011 | Oran B, Wagner JE, DeFor TE, Weisdorf DJ, Brunstein CG. Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 1327-34. PMID 21232621 DOI: 10.1016/j.bbmt.2011.01.007 | 0.336 | |||
| 2011 | Warlick ED, Tomblyn M, Cao Q, DeFor T, Blazar BR, MacMillan M, Verneris M, Wagner J, Dusenbery K, Aurora M, Bachanova V, Brunstein C, Burns L, Cooley S, Kaufman D, et al. Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive Non-Hodgkin lymphomas Biology of Blood and Marrow Transplantation. 17: 1025-1032. PMID 21047561 DOI: 10.1016/J.Bbmt.2010.10.030 | 0.335 | |||
| 2011 | Burke MJ, Vogel RI, Janardan SK, Brunstein C, Smith AR, Miller JS, Weisdorf D, Wagner JE, Verneris MR. Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 831-40. PMID 20831896 DOI: 10.1016/j.bbmt.2010.08.022 | 0.33 | |||
| 2011 | Smith AR, Gulbahce E, Burke MJ, Cao Q, Macmillan ML, Tolar J, Orchard PJ, Blazar BR, Baker KS, Wagner JE, Verneris MR. Lower leukemia relapse in pediatric patients with pulmonary cytolytic thrombi following allogeneic transplant. Bone Marrow Transplantation. 46: 368-71. PMID 20548337 DOI: 10.1038/Bmt.2010.119 | 0.316 | |||
| 2011 | Honebrink T, Dayton VJ, Larsen K, Cao Q, Brunstein C, Weisdorf DJ, Miller JS, Wagner JE, Verneris MR. The Impact of Bone Marrow Hematogones on Umbilical Cord Blood Transplant Outcomes in Acute Myeloid Leukemia Patients, Blood. 118: 4148-4148. DOI: 10.1182/BLOOD.V118.21.4148.4148 | 0.365 | |||
| 2011 | Majhail N, Brunstein C, Warlick E, Oran B, Shanley R, Sandhu K, Wagner J, Weisdorf D. Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes: Comparable Outcomes With Unrelated Umbilical Cord Blood and HLA-Identical Sibling Donors Biology of Blood and Marrow Transplantation. 17: S155. DOI: 10.1016/J.BBMT.2010.12.015 | 0.362 | |||
| 2010 | Brunstein CG, Gutman JA, Weisdorf DJ, Woolfrey AE, Defor TE, Gooley TA, Verneris MR, Appelbaum FR, Wagner JE, Delaney C. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood. 116: 4693-9. PMID 20686119 DOI: 10.1182/blood-2010-05-285304 | 0.336 | |||
| 2010 | Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, Sirvent A, Champlin RE, Chao N, Gee AP, Isola L, Laughlin MJ, Marks DI, Nabhan S, Ruggeri A, ... ... Wagner JE, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. The Lancet. Oncology. 11: 653-60. PMID 20558104 DOI: 10.1016/S1470-2045(10)70127-3 | 0.362 | |||
| 2010 | Ramirez PA, Wagner JE, Brunstein CG. Going straight to the point: intra-BM injection of hematopoietic progenitors. Bone Marrow Transplantation. 45: 1127-33. PMID 20305702 DOI: 10.1038/bmt.2010.39 | 0.301 | |||
| 2010 | Verneris MR, Eapen M, Duerst R, Carpenter PA, Burke MJ, Afanasyev BV, Cowan MJ, He W, Krance R, Li CK, Tan PL, Wagner JE, Davies SM. Reduced-intensity conditioning regimens for allogeneic transplantation in children with acute lymphoblastic leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 1237-44. PMID 20302960 DOI: 10.1016/j.bbmt.2010.03.009 | 0.384 | |||
| 2010 | MacMillan ML, Wagner JE. Haematopoeitic cell transplantation for Fanconi anaemia - when and how? British Journal of Haematology. 149: 14-21. PMID 20136826 DOI: 10.1111/j.1365-2141.2010.08078.x | 0.349 | |||
| 2010 | Eapen M, Wagner JE. Transplant outcomes in acute leukemia. I. Seminars in Hematology. 47: 46-50. PMID 20109611 DOI: 10.1053/j.seminhematol.2009.10.007 | 0.394 | |||
| 2010 | Wagner JE, Gluckman E. Umbilical cord blood transplantation: the first 20 years. Seminars in Hematology. 47: 3-12. PMID 20109607 DOI: 10.1053/j.seminhematol.2009.10.011 | 0.357 | |||
| 2010 | Beck JC, Wagner JE, DeFor TE, Brunstein CG, Schleiss MR, Young JA, Weisdorf DH, Cooley S, Miller JS, Verneris MR. Impact of Cytomegalovirus (CMV) Reactivation after Umbilical Cord Blood Transplantation Biology of Blood and Marrow Transplantation. 16: 215-222. PMID 19786112 DOI: 10.1016/j.bbmt.2009.09.019 | 0.34 | |||
| 2010 | Wagner JE, Laughlin M, Petz L. Seventh Annual International Umbilical Cord Blood Transplantation Symposium, Los Angeles, California, June 5-6, 2009. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 12-27. PMID 19748592 DOI: 10.1016/j.bbmt.2009.08.023 | 0.334 | |||
| 2010 | Majhail NS, Mothukuri JM, Macmillan ML, Verneris MR, Orchard PJ, Wagner JE, Weisdorf DJ. Costs of pediatric allogeneic hematopoietic-cell transplantation. Pediatric Blood & Cancer. 54: 138-43. PMID 19693941 DOI: 10.1002/pbc.22250 | 0.319 | |||
| 2010 | Oran B, Wagner JE, Defor T, Weisdorf DJ, Brunstein C. Reduced Intensity Versus Myeloablative Conditioning in Adults with Acute Myeloid Leukemia Transplanted with Umbilical Cord Blood Blood. 116: 3531-3531. DOI: 10.1182/BLOOD.V116.21.3531.3531 | 0.345 | |||
| 2010 | MacMillan ML, Blazar BR, Defor TE, Dusenbery KE, Verneris MR, Zierhut H, Wagner JE. Alternative Donor Hematopoietic Cell Transplantation In 94 Patients with Fanconi Anemia at the University of Minnesota Blood. 116: 3526-3526. DOI: 10.1182/Blood.V116.21.3526.3526 | 0.318 | |||
| 2010 | Romee R, Weisdorf DJ, Brunstein C, Wagner JE, Blazar BR, Majhail NS, Vercellotti GM, Miller JS, Arora M. ABO Mismatch Adversely Affects GvHD In Recipients of HLA Matched Unrelated Marrow or Peripheral Blood but Not Single or Double Umbilical Cord Blood Transplants Blood. 116: 226-226. DOI: 10.1182/Blood.V116.21.226.226 | 0.397 | |||
| 2010 | Ramirez PA, Wagner JE, Defor T, Blazar BR, Verneris M, Miller JS, Weisdorf DJ, McGlave P, Brunstein C. Kinetics of Chimerism and Unit Predominance After Double Umbilical Cord Blood Transplantation Blood. 116: 225-225. DOI: 10.1182/Blood.V116.21.225.225 | 0.306 | |||
| 2010 | Eapen M, Wang T, Kurtzberg J, Lee SJ, Duerst R, Arora M, Bonfim C, Duval M, Eames G, Tiedemann K, Weisdorf DJ, Wagner JE. Chronic Graft-Versus-Host Disease and Its Association with Treatment-Related Mortality, Relapse, Leukemia-Free and Overall Survival After Umbilical Cord Blood Transplantation (UCBT) In Children and Adolescents with Acute Leukemia Blood. 116: 213-213. DOI: 10.1182/Blood.V116.21.213.213 | 0.358 | |||
| 2010 | Dietz AC, Jackson S, Hirsch BA, Brunstein C, Wagner JE. Donor-Derived Myelodysplastic Syndrome and Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Incidence, Natural History and Treatment Response Blood. 116: 1306-1306. DOI: 10.1182/BLOOD.V116.21.1306.1306 | 0.381 | |||
| 2009 | Wagner JE. Should double cord blood transplants be the preferred choice when a sibling donor is unavailable? Best Practice and Research: Clinical Haematology. 22: 551-555. PMID 19959107 DOI: 10.1016/j.beha.2009.09.003 | 0.379 | |||
| 2009 | Orchard PJ, Milla C, Braunlin E, DeFor T, Bjoraker K, Blazar BR, Peters C, Wagner J, Tolar J. Pre-transplant risk factors affecting outcome in Hurler syndrome. Bone Marrow Transplantation. 45: 1239-46. PMID 19898501 DOI: 10.1038/Bmt.2009.319 | 0.318 | |||
| 2009 | Blaes AH, Cao Q, Wagner JE, Young JA, Weisdorf DJ, Brunstein CG. Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 287-91. PMID 19835968 DOI: 10.1016/j.bbmt.2009.10.008 | 0.306 | |||
| 2009 | Smith AR, Wagner JE. Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood. British Journal of Haematology. 147: 246-61. PMID 19796274 DOI: 10.1111/j.1365-2141.2009.07828.x | 0.358 | |||
| 2009 | Wagner JE, Brunstein C, Tse W, Laughlin M. Umbilical cord blood transplantation. Cancer Treatment and Research. 144: 233-55. PMID 19779887 DOI: 10.1007/978-0-387-78580-6_10 | 0.331 | |||
| 2009 | Verneris MR, Brunstein CG, Barker J, MacMillan ML, DeFor T, McKenna DH, Burke MJ, Blazar BR, Miller JS, McGlave PB, Weisdorf DJ, Wagner JE. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood. 114: 4293-9. PMID 19706886 DOI: 10.1182/Blood-2009-05-220525 | 0.363 | |||
| 2009 | Smith AR, Baker KS, Defor TE, Verneris MR, Wagner JE, Macmillan ML. Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 1086-93. PMID 19660721 DOI: 10.1016/j.bbmt.2009.05.005 | 0.38 | |||
| 2009 | Tomblyn MB, Arora M, Baker KS, Blazar BR, Brunstein CG, Burns LJ, DeFor TE, Dusenbery KE, Kaufman DS, Kersey JH, MacMillan ML, McGlave PB, Miller JS, Orchard PJ, Slungaard A, ... ... Wagner JE, et al. Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 3634-41. PMID 19581540 DOI: 10.1200/Jco.2008.20.2960 | 0.321 | |||
| 2009 | McCullough J, McKenna D, Kadidlo D, Maurer D, Noreen HJ, French K, Brunstein C, Wagner JE. Mislabeled units of umbilical cord blood detected by a quality assurance program at the transplantation center. Blood. 114: 1684-8. PMID 19487257 DOI: 10.1182/Blood-2009-02-205047 | 0.333 | |||
| 2009 | Lazarus HM, Kan F, Tarima S, Champlin RE, Confer DL, Frey N, Gee AP, Wagner JE, Horowitz MM, Eapen M. Rapid Transport and Infusion of Hematopoietic Cells Is Associated with Improved Outcome after Myeloablative Therapy and Unrelated Donor Transplant Biology of Blood and Marrow Transplantation. 15: 589-596. PMID 19361751 DOI: 10.1016/J.Bbmt.2009.01.017 | 0.356 | |||
| 2009 | Reed W, Noga SJ, Gee AP, Rooney CM, Wagner JE, McCullough J, McKenna DH, Whiteside TL, Donnenberg AD, Baker AK, Lindblad RW, Wagner EL, Mondoro TH. Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies. Transfusion. 49: 786-96. PMID 19170985 DOI: 10.1111/J.1537-2995.2008.02027.X | 0.461 | |||
| 2009 | Brunstein CG, Cantero S, Cao Q, Majhail N, McClune B, Burns LJ, Tomblyn M, Miller JS, Blazar BR, McGlave PB, Weisdorf DJ, Wagner JE. Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 214-22. PMID 19167681 DOI: 10.1016/J.Bbmt.2008.11.013 | 0.337 | |||
| 2009 | Brunstein CG, Barker JN, Weisdorf DJ, Defor TE, McKenna D, Chong SY, Miller JS, McGlave PB, Wagner JE. Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplantation. 43: 935-40. PMID 19139736 DOI: 10.1038/bmt.2008.417 | 0.338 | |||
| 2009 | Rodrigues CA, Sanz G, Brunstein CG, Sanz J, Wagner JE, Renaud M, de Lima M, Cairo MS, Fürst S, Rio B, Dalley C, Carreras E, Harousseau JL, Mohty M, Taveira D, et al. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 256-63. PMID 19064984 DOI: 10.1200/JCO.2007.15.8865 | 0.343 | |||
| 2009 | MacMillan ML, Weisdorf DJ, Brunstein CG, Cao Q, DeFor TE, Verneris MR, Blazar BR, Wagner JE. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood. 113: 2410-5. PMID 18997171 DOI: 10.1182/Blood-2008-07-163238 | 0.35 | |||
| 2009 | MacMillan ML, Blazar BR, DeFor TE, Wagner JE. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: Results of a phase I-II clinical trial Bone Marrow Transplantation. 43: 447-454. PMID 18955980 DOI: 10.1038/Bmt.2008.348 | 0.349 | |||
| 2009 | Rodrigues CA, Canals C, Brunstein C, Finke J, Nagler A, Maertens J, Harousseau J, Niederwieser D, Ringden O, Cornelissen JJ, Ruutu T, Russell NH, Guilhot F, Rio B, Blaise D, ... Wagner JE, et al. Comparison of Outcomes After Unrelated Cord Blood Transplantation and Matched Unrelated Donor RIC Transplantation for Lymphoid Malignancies - A Eurocord-Netcord Group/ Lymphoma Working Party and Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Study. Blood. 114: 663-663. DOI: 10.1182/BLOOD.V114.22.663.663 | 0.335 | |||
| 2009 | Brunstein CG, Gutman JA, DeFor TE, Gooley T, Verneris MR, Woolfrey A, Weisdorf DJ, Appelbaum FR, Wagner JE, Delaney C. Reduced Relapse and Similar Progression-Free Survival After Double Umbilical Cord Blood Transplantation (DUCBT): Comparison of Outcomes Between Sibling, Unrelated Adult and Unrelated DUCB Hematopoietic Stem Cell (HSC) Donors. Blood. 114: 662-662. DOI: 10.1182/BLOOD.V114.22.662.662 | 0.356 | |||
| 2009 | Verneris M, Janardan S, Isaksson R, Brunstein C, Weisdorf D, Miller J, Wagner J. Rapid Recovery of Absolute Lymphocyte Counts (ALC) is Predictive of Favorable Outcomes Following Umbilical Cord Blood (UCB) Transplantation: Impact of the Use of Two UCB Units Biology of Blood and Marrow Transplantation. 15: 19-20. DOI: 10.1016/J.BBMT.2008.12.058 | 0.302 | |||
| 2009 | Brunstein CG, Weisdorf DJ, DeFor TE, Miller JS, McGlave PB, Blazar BR, Wagner JE. Favorable Leukemia-Free Survival (LFS) for Adults and Children Undergoing Myeloablative Umbilical Cord Blood (UCB) Transplantation with Cyclophosphamide (CY), Fludarabine (FLU) and Total Body Irradiation (TBI): A Single Center Analysis of 194 Patients Biology of Blood and Marrow Transplantation. 15: 5. DOI: 10.1016/J.Bbmt.2008.12.015 | 0.31 | |||
| 2009 | Wagner JE, MacMillan ML, Auerbach AD. Hematopoietic Cell Transplantation for Fanconi's Anemia Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition. 1178-1199. DOI: 10.1002/9781444303537.ch79 | 0.333 | |||
| 2008 | Krishnamurti L, Kharbanda S, Biernacki MA, Zhang W, Baker KS, Wagner JE, Wu CJ. Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 1270-8. PMID 18940682 DOI: 10.1016/j.bbmt.2008.08.016 | 0.372 | |||
| 2008 | Pasquini R, Carreras J, Pasquini MC, Camitta BM, Fasth AL, Hale GA, Harris RE, Marsh JC, Robinson AJ, Zhang MJ, Eapen M, Wagner JE. HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 1141-7. PMID 18804044 DOI: 10.1016/j.bbmt.2008.06.020 | 0.326 | |||
| 2008 | Kurtzberg J, Prasad VK, Carter SL, Wagner JE, Baxter-Lowe LA, Wall D, Kapoor N, Guinan EC, Feig SA, Wagner EL, Kernan NA. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood. 112: 4318-27. PMID 18723429 DOI: 10.1182/blood-2007-06-098020 | 0.53 | |||
| 2008 | Majhail NS, Brunstein CG, McAvoy S, DeFor TE, Al-Hazzouri A, Setubal D, Arora M, Le CT, Wagner JE, Weisdorf DJ. Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 985-92. PMID 18721761 DOI: 10.1016/j.bbmt.2008.06.008 | 0.336 | |||
| 2008 | Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 685-92. PMID 18489994 DOI: 10.1016/J.Bbmt.2008.03.011 | 0.335 | |||
| 2008 | Majhail NS, Brunstein CG, Tomblyn M, Thomas AJ, Miller JS, Arora M, Kaufman DS, Burns LJ, Slungaard A, McGlave PB, Wagner JE, Weisdorf DJ. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 282-9. PMID 18275894 DOI: 10.1016/j.bbmt.2007.12.488 | 0.374 | |||
| 2008 | Cairo MS, Rocha V, Gluckman E, Hale G, Wagner J. Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 44-53. PMID 18162220 DOI: 10.1016/j.bbmt.2007.10.007 | 0.349 | |||
| 2008 | Tan P, Yeoh A, Quah T, Kurtzberg J, Wagner JE. High Probability of Survival after Related and Alternate Donor Hematopoietic Cell Transplantation for Pediatric Patients with High Risk AML Using a Fludarabine Based Preparative Regimen Blood. 112: 4430-4430. DOI: 10.1182/BLOOD.V112.11.4430.4430 | 0.371 | |||
| 2008 | Bachanova V, Weisdorf DJ, Brunstein C, Wagner J, Verneris M. Prolonged Survival in Adults with Acute Lymphoblastic Leukemia (ALL) Following Reduced Intensity Conditioning and Allogeneic Transplantation Blood. 112: 4415-4415. DOI: 10.1182/BLOOD.V112.11.4415.4415 | 0.344 | |||
| 2008 | Eapen M, Rocha V, Scaradavou A, Gluckman E, Laughlin M, Stevens C, Horowitz MM, Wagner JE. Effect of Stem Cell Source on Transplant Outcomes in Adults with Acute Leukemia: A Comparison of Unrelated Bone Marrow (BM), Peripheral Blood (PB) and Cord Blood (CB) Blood. 112: 151-151. DOI: 10.1182/BLOOD.V112.11.151.151 | 0.384 | |||
| 2008 | Arora M, Nagaraj S, DeFor T, MacMillan M, Wagner J, Burns L, Weisdorf D. 351: Chronic Graft-Versus-Host Disease (CGVHD) Following Sibling Donor Peripheral Blood Stem Cell Transplant (PBSCT) Versus Bone Marrow Transplant (BMT): Greater Incidence and Longer Duration of Immune-Suppression (DIS) using PBSC Biology of Blood and Marrow Transplantation. 14: 128-129. DOI: 10.1016/J.BBMT.2007.12.361 | 0.361 | |||
| 2008 | MacMillan ML, Wagner JE, Arora M, DeFor TE, Blazar BR, Weisdorf DJ. 340: Response to Steroids as Primary Therapy for Acute Graft-Versus-Host Disease (GVHD) in 280 Hematopoietic Stem Cell Transplant (HSCT) Recipients: Comparison of Unrelated Donor (URD) Bone Marrow (BM) and Umbilical Cord Blood (UCB) Biology of Blood and Marrow Transplantation. 14: 125. DOI: 10.1016/J.Bbmt.2007.12.350 | 0.369 | |||
| 2008 | Martinez C, Orchard P, Wagner J, Petryk A, Tolar J. 219: Hypercalcemia after Hematopoietic Stem Cell Transplantation for Osteopetrosis Biology of Blood and Marrow Transplantation. 14: 82. DOI: 10.1016/J.BBMT.2007.12.228 | 0.323 | |||
| 2008 | Verneris MR, Gulbahce E, Burke M, Cao Q, MacMillan ML, Tolar J, Orchard P, Blazar BR, Baker S, Wagner JE. 218: Lower Leukemia Relapse in Patients with Pulmonary Cytolytic Thrombi after Allogeneic Hematopoietic Cell Transplant Biology of Blood and Marrow Transplantation. 14: 81-82. DOI: 10.1016/J.Bbmt.2007.12.227 | 0.339 | |||
| 2008 | Rodrigues C, Sanz G, Brunstein C, Renaud M, Blaise D, Rio B, Cairo M, de Lima M, Sureda A, Wagner J, Gluckman E, Rocha V. 168: Unrelated Cord Blood Transplantation in Adults with Lymphoid Malignancies. A Eurocord/EBMT-Lymphoma Working Party Study Biology of Blood and Marrow Transplantation. 14: 62-63. DOI: 10.1016/J.BBMT.2007.12.177 | 0.302 | |||
| 2008 | Martinez C, Tolar J, Wagner J, Tan P, DeFor T, Baker K, Orchard P. 39: Feasibility of Unrelated Umbilical Cord Blood Transplantation in Congenital Childhood Diseases Biology of Blood and Marrow Transplantation. 14: 17. DOI: 10.1016/J.BBMT.2007.12.047 | 0.324 | |||
| 2008 | Doshi K, Brunstein C, Cao Q, Wagner J. 9: Risk Factors Associated with Graft Failure After Umbilical Cord Blood Transplantation (UCBT): A Single Center Analysis in 539 Patients Biology of Blood and Marrow Transplantation. 14: 5-6. DOI: 10.1016/j.bbmt.2007.12.017 | 0.321 | |||
| 2007 | van Burik JAH, Carter SL, Freifeld AG, High KP, Godder KT, Papanicolaou GA, Mendizabal AM, Wagner JE, Yanovich S, Kernan NA. Higher Risk of Cytomegalovirus and Aspergillus Infections in Recipients of T Cell-Depleted Unrelated Bone Marrow: Analysis of Infectious Complications in Patients Treated with T Cell Depletion Versus Immunosuppressive Therapy to Prevent Graft-versus-Host Disease Biology of Blood and Marrow Transplantation. 13: 1487-1498. PMID 18022579 DOI: 10.1016/J.Bbmt.2007.08.049 | 0.305 | |||
| 2007 | Copelan E, Casper JT, Carter SL, van Burik JAH, Hurd D, Mendizabal AM, Wagner JE, Yanovich S, Kernan NA. A Scheme for Defining Cause of Death and Its Application in the T Cell Depletion Trial Biology of Blood and Marrow Transplantation. 13: 1469-1476. PMID 18022577 DOI: 10.1016/j.bbmt.2007.08.047 | 0.373 | |||
| 2007 | Eapen M, Logan BR, Confer DL, Haagenson M, Wagner JE, Weisdorf DJ, Wingard JR, Rowley SD, Stroncek D, Gee AP, Horowitz MM, Anasetti C. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 1461-8. PMID 18022576 DOI: 10.1016/J.Bbmt.2007.08.006 | 0.373 | |||
| 2007 | Wagner J, Champlin R, Petz LD. Fifth Annual International Umbilical Cord Blood Transplantation Symposium, Los Angeles, California, May 11-12, 2007. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 1380-92. PMID 17950924 DOI: 10.1016/J.BBMT.2007.08.007 | 0.334 | |||
| 2007 | Arora M, Nagaraj S, Wagner JE, Barker JN, Brunstein CG, Burns LJ, Defor TE, McMillan ML, Miller JS, Weisdorf DJ. Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB). Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 1145-52. PMID 17889350 DOI: 10.1016/J.BBMT.2007.06.004 | 0.366 | |||
| 2007 | Gluckman E, Rocha V, Ionescu I, Bierings M, Harris RE, Wagner J, Kurtzberg J, Champagne MA, Bonfim C, Bittencourt M, Darbyshire P, Fernandez MN, Locatelli F, Pasquini R. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 1073-82. PMID 17697970 DOI: 10.1016/j.bbmt.2007.05.015 | 0.326 | |||
| 2007 | Adamkiewicz TV, Szabolcs P, Haight A, Baker KS, Staba S, Kedar A, Chiang KY, Krishnamurti L, Boyer MW, Kurtzberg J, Wagner JE, Wingard JR, Yeager AM. Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience. Pediatric Transplantation. 11: 641-4. PMID 17663687 DOI: 10.1111/j.1399-3046.2007.00725.x | 0.317 | |||
| 2007 | Flynn CM, Hirsch B, Defor T, Barker JN, Miller JS, Wagner JE, Blazar BR, Burns LJ, Macmillan ML, Arora M, Weisdorf D. Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysis. American Journal of Hematology. 82: 867-72. PMID 17616969 DOI: 10.1182/Blood.V104.11.1817.1817 | 0.35 | |||
| 2007 | Brunstein CG, Barker JN, Weisdorf DJ, DeFor TE, Miller JS, Blazar BR, McGlave PB, Wagner JE. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood. 110: 3064-70. PMID 17569820 DOI: 10.1182/Blood-2007-04-067215 | 0.377 | |||
| 2007 | Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, Loberiza FR, Champlin RE, Klein JP, Horowitz MM, Wagner JE. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 369: 1947-54. PMID 17560447 DOI: 10.1016/S0140-6736(07)60915-5 | 0.374 | |||
| 2007 | Brunstein CG, Setubal DC, Wagner JE. Expanding the role of umbilical cord blood transplantation British Journal of Haematology. 137: 20-35. PMID 17359369 DOI: 10.1111/j.1365-2141.2007.06521.x | 0.383 | |||
| 2007 | Brunstein CG, Baker KS, Wagner JE. Umbilical cord blood transplantation for myeloid malignancies Current Opinion in Hematology. 14: 162-169. PMID 17255794 DOI: 10.1097/MOH.0b013e32802f7da4 | 0.398 | |||
| 2007 | Markova M, Barker JN, Miller JS, Arora M, Wagner JE, Burns LJ, MacMillan ML, Douek D, DeFor T, Tan Y, Repka T, Blazar BR, Weisdorf DJ. Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial. Bone Marrow Transplantation. 39: 193-9. PMID 17220905 DOI: 10.1038/Sj.Bmt.1705556 | 0.306 | |||
| 2007 | Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F, Zhang MJ, Auerbach AD. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood. 109: 2256-62. PMID 17038525 DOI: 10.1182/blood-2006-07-036657 | 0.368 | |||
| 2007 | Majhail NS, Brunstein C, Wagner JE, Tomblyn M, Thomas A, Miller JS, Arora M, Kaufman DS, Burns LJ, Slungaard A, McGlave PB, Weisdorf DJ. Reduced Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related Donor. Blood. 110: 331-331. DOI: 10.1182/BLOOD.V110.11.331.331 | 0.331 | |||
| 2007 | Lazarus HM, Kan F, Tarima S, Champlin RE, Confer D, Frey N, Giralt S, Wagner JE, Horowitz MM, Eapen M. Rapid Transport and Infusion of Hematopoietic Stem Cells Can Improve Outcome after Unrelated Donor Transplant. Blood. 110: 3063-3063. DOI: 10.1182/Blood.V110.11.3063.3063 | 0.334 | |||
| 2007 | Rocha V, Rio B, Brunstein C, Renaud M, Olivieri A, Sirvent A, Tabrizi R, Uzunov M, Boudjedir K, Ionescu I, Rodrigues CA, Gluckman E, Blaise D, Wagner JE. Unrelated Cord Blood Transplantation after Reduced Intensity Conditioning (RIC) in Adults with Hematological Malignancy. An EBMT-Eurocord-Netcord, Société Française de Greffe de Moelle et de Thérapie Cellulaire and University of Minnesota Collaborative Study. Blood. 110: 2027-2027. DOI: 10.1182/blood.v110.11.2027.2027 | 0.363 | |||
| 2007 | Rodrigues CA, Brunstein C, Sanz G, Renaud M, de Lima M, Blaise D, Rio B, Madureira AB, Sureda A, Wagner JE, Gluckman E, Rocha V. Cord Blood Transplantation from Unrelated Donors for Adults with Advanced Lymphoid Malignancies - A Eurocord-Netcord Group/EBMT-LWP Study. Blood. 110: 2025-2025. DOI: 10.1182/BLOOD.V110.11.2025.2025 | 0.361 | |||
| 2007 | Tolar J, Orchard PJ, Miller JS, MacMillan ML, Wagner JE, Alter BP, Baker K. Dyskeratosis Congenita: Low Regimen-Related Toxicity Following Hematopoietic Cell Transplantation (HCT) Using a Reduced Intensity Conditioning Regimen. Blood. 110: 2005-2005. DOI: 10.1182/blood.v110.11.2005.2005 | 0.382 | |||
| 2007 | Lamb LS, Wagner JE, Kernan NA, Small TN, Carter SL, Thompson JS, Cloud GA, Meleth S, Kumar A, Keever-Taylor CA. Effect of Graft Engineering and Post-Transplantation Immunosuppression Regimen on Immunophenotypic Recovery in Recipients of Unrelated Donor Bone Marrow (T-Cell Depletion Trial) in a Multicenter Randomized Phase II-III Trial. Blood. 110: 1067-1067. DOI: 10.1182/Blood.V110.11.1067.1067 | 0.324 | |||
| 2007 | Alexander L, Wagner J. Alternative Donor Options for Hematopoietic Stem Cell Transplantation Md Conference Express. 7: 9-34. DOI: 10.1177/155989770700700302 | 0.342 | |||
| 2007 | Miller JS, Brunstein CG, Cooley S, Verneris MR, Panoskaltsis-Mortari A, Burns LJ, McKenna D, Dusenbery K, Stevens C, Rubenstein P, Tomblyn M, Arora M, MacMillan ML, Defor T, Le C, ... ... Wagner JE, et al. 29: A Novel Triple Umbilical Cord Blood Transplant (UCBT) Strategy to Promote NK Cell Immunotherapy (Unit 1) with a Fully Ablative Preparative Regimen Followed By a Double UCBT in Patients with Refractory AML Biology of Blood and Marrow Transplantation. 13: 1403. DOI: 10.1016/j.bbmt.2007.08.037 | 0.359 | |||
| 2007 | Brunstein CG, DeFor T, Wagner JE. 16: Nonmyeloablative Umbilical Cord Blood Transplantation Biology of Blood and Marrow Transplantation. 13: 1398. DOI: 10.1016/J.BBMT.2007.08.024 | 0.333 | |||
| 2007 | Wagner JE, Brunstein C. 5: Double Umbilical Cord Blood Transplantation after Myeloablation Biology of Blood and Marrow Transplantation. 13: 1394. DOI: 10.1016/J.BBMT.2007.08.013 | 0.335 | |||
| 2007 | Brunstein C, Setubal D, DeFor T, Weisdorf D, McGlave P, Miller J, Wagner J. 229: Umbilical cord blood transplantation for adult patients with chronic myeloid leukemia Biology of Blood and Marrow Transplantation. 13: 84. DOI: 10.1016/J.BBMT.2006.12.234 | 0.318 | |||
| 2007 | MacMillan M, Brunstein C, DeFor T, Blazar B, Weisdorf D, Wagner J. 32: Single versus double umbilical cord blood transplantation (UCBT) Biology of Blood and Marrow Transplantation. 13: 14. DOI: 10.1016/J.Bbmt.2006.12.035 | 0.338 | |||
| 2006 | Brunstein CG, Wagner JE. Cord blood transplantation for adults Vox Sanguinis. 91: 195-205. PMID 16958831 DOI: 10.1111/j.1423-0410.2006.00823.x | 0.376 | |||
| 2006 | Parkman R, Cohen G, Carter SL, Weinberg KI, Masinsin B, Guinan E, Kurtzberg J, Wagner JE, Kernan NA. Successful Immune Reconstitution Decreases Leukemic Relapse and Improves Survival in Recipients of Unrelated Cord Blood Transplantation Biology of Blood and Marrow Transplantation. 12: 919-927. PMID 16920557 DOI: 10.1016/J.Bbmt.2006.05.008 | 0.371 | |||
| 2006 | Majhail NS, Brunstein CG, Wagner JE. Double umbilical cord blood transplantation Current Opinion in Immunology. 18: 571-575. PMID 16895752 DOI: 10.1016/j.coi.2006.07.015 | 0.381 | |||
| 2006 | Brunstein CG, Weisdorf DJ, DeFor T, Barker JN, Tolar J, van Burik JA, Wagner JE. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood. 108: 2874-80. PMID 16804113 DOI: 10.1182/BLOOD-2006-03-011791 | 0.382 | |||
| 2006 | Schoemans H, Theunissen K, Maertens J, Boogaerts M, Verfaillie C, Wagner J. Adult umbilical cord blood transplantation: a comprehensive review Bone Marrow Transplantation. 38: 83-93. PMID 16751788 DOI: 10.1038/Sj.Bmt.1705403 | 0.377 | |||
| 2006 | Martin PL, Carter SL, Kernan NA, Sahdev I, Wall D, Pietryga D, Wagner JE, Kurtzberg J. Results of the Cord Blood Transplantation Study (COBLT): Outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases Biology of Blood and Marrow Transplantation. 12: 184-194. PMID 16443516 DOI: 10.1016/j.bbmt.2005.09.016 | 0.392 | |||
| 2006 | Brunstein CG, Wagner JE. Umbilical cord blood transplantation and banking Annual Review of Medicine. 57: 403-417. PMID 16409157 DOI: 10.1146/annurev.med.57.051804.123642 | 0.35 | |||
| 2006 | Eapen M, Rubinstein P, Zhang MJ, Camitta BM, Stevens C, Cairo MS, Davies SM, Doyle JJ, Kurtzberg J, Pulsipher MA, Ortega JJ, Scaradavou A, Horowitz MM, Wagner JE. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 145-51. PMID 16382124 DOI: 10.1200/JCO.2005.02.4612 | 0.341 | |||
| 2006 | Tan PL, Wagner JE, Auerbach AD, Defor TE, Slungaard A, Macmillan ML. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatric Blood & Cancer. 46: 630-6. PMID 16078221 DOI: 10.1002/pbc.20538 | 0.4 | |||
| 2006 | Brunstein CG, Setubal D, Tomblyn M, DeFor T, Arora M, Burns LJ, Miller JS, Weisdorf DJ, Wagner JE. Umbilical Cord Blood Transplant after Reduced Intensity Conditioning Provides Outcomes Comparable HLA-Matched Siblings for Patients with High Risk and Advanced Acute Myeloid Leukemia. Blood. 108: 606-606. DOI: 10.1182/BLOOD.V108.11.606.606 | 0.343 | |||
| 2006 | MacMillan ML, Brunstein C, DeFor TE, Blazar BR, Weisdorf DJ, Wagner JE. Single Versus Double Umbilical Cord Blood Transplantation (UCBT): Higher Risk of Acute Graft-Versus-Host Disease (GVHD) but Lower Transplant Related Mortality (TRM) in Recipients of Double UCBT. Blood. 108: 435-435. DOI: 10.1182/Blood.V108.11.435.435 | 0.357 | |||
| 2006 | Eapen M, Rubinstein P, Zhang M, Stevens C, Kurtzberg J, Scaradavou A, Horowitz MM, Wagner JE. Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT) in Children with Acute Leukemia: Risks and Benefits of Umbilical Cord Blood (CB) Versus HLA A, B, C, DRB1 Allele-Matched Bone Marrow (BM). Blood. 108: 434-434. DOI: 10.1182/Blood.V108.11.434.434 | 0.319 | |||
| 2006 | MacMillan ML, Blazar BR, DeFor TE, Dusenbery K, Wagner JE. Thymic Shielding (TS) in Recipients of Total Body Irradiation (TBI) and Alternative Donor Hematopoietic Stem Cell Transplant (AD-HSCT): Reduced Risk of Opportunistic Infection in Patients with Fanconi Anemia (FA). Blood. 108: 3134-3134. DOI: 10.1182/BLOOD.V108.11.3134.3134 | 0.306 | |||
| 2006 | Harker-Murray PD, Verneris MR, Thomas AJ, Luo X, MacMillan ML, Tolar J, Baker KS, Wagner JE, Orchard PJ. Hematopoietic Cell Transplantation as Therapy for Pediatric Patients with Relapsed Acute Lymphoblastic Leukemia with and without CNS Involvement. Blood. 108: 3110-3110. DOI: 10.1182/Blood.V108.11.3110.3110 | 0.326 | |||
| 2006 | MacMillan ML, Blazar BR, DeFor TE, Dusenbery K, Wagner JE. Thymic Shielding (TS) in Recipients of Total Body Irradiation (TBI) and Alternative Donor Hematopoietic Stem Cell Transplant (AD-HSCT): Reduced Risk of Opportunistic Infection in Patients with Fanconi Anemia (FA). Blood. 108: 3134-3134. DOI: 10.1016/J.Bbmt.2006.12.049 | 0.306 | |||
| 2006 | Miller JS, Brunstein CG, McKenna DH, Wagner JE. 19: NK Cells and KIR Mismatch in Cord Blood Transplantation Biology of Blood and Marrow Transplantation. 12: 1224. DOI: 10.1016/J.BBMT.2006.08.021 | 0.341 | |||
| 2006 | Kumar P, Defor TE, Brunstein C, Barker JN, Wagner JE, Weisdorf DJ, Miller JS, McGlave P, Slungaard A, Arora M, Tomblyn M, Burns LJ. 10: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Treatment of Acute Lymphocytic Leukemia (ALL) in 126 Adults Biology of Blood and Marrow Transplantation. 12: 1221. DOI: 10.1016/J.BBMT.2006.08.012 | 0.322 | |||
| 2006 | Verneris MR, Brunstein C, DeFor TE, Barker J, Weisdorf DJ, Blazar BR, Miller JS, Wagner JE. 6: Risk of Relapse after Umbilical Cord Blood Transplantation in Patients with Acute Leukemia: Marked Reduction in Recipients of Two Units Biology of Blood and Marrow Transplantation. 12: 1219. DOI: 10.1016/J.Bbmt.2006.08.008 | 0.35 | |||
| 2006 | Baker KS, Wagner JE. 4: Double Umbilical Cord Transplants (UCBT) with Myeloablative or Reduced Intensity Conditioning Regimens (RIC) Biology of Blood and Marrow Transplantation. 12: 1218-1219. DOI: 10.1016/J.BBMT.2006.08.006 | 0.31 | |||
| 2006 | Wagner JE. 1: Umbilical Cord Blood Transplantation Biology of Blood and Marrow Transplantation. 12: 1218. DOI: 10.1016/J.BBMT.2006.08.003 | 0.331 | |||
| 2006 | Majhail N, Defor T, Brunstein C, Wagner J, Weisdorf D, Miller J, Arora M, Tomblyn M, McGlave P, Slungaard A, Burns L. Comparable results of umbilical cord blood and HLA matched sibling donor hematopoietic stem cell transplant after reduced-intensity preparative regimen for advanced Hodgkin’s lymphoma Biology of Blood and Marrow Transplantation. 12: 75. DOI: 10.1016/J.BBMT.2005.11.236 | 0.383 | |||
| 2006 | Kernan N, Carter S, Wagner J, Baxter-Lowe L, Wall D, Kapoor N, Guinan E, Wagner E, Geller N, Kurtzberg J. Umbilical cord blood transplantation in pediatric patients: Results of the prospective, multi-institutional Cord Blood Transplantation Study (COBLT) Biology of Blood and Marrow Transplantation. 12: 14-15. DOI: 10.1016/J.BBMT.2005.11.048 | 0.349 | |||
| 2005 | Majhail NS, Weisdorf DJ, Wagner JE, Defor TE, Brunstein CG, Burns LJ. Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma. Blood. 107: 3804-7. PMID 16384924 DOI: 10.1182/BLOOD-2005-09-3827 | 0.37 | |||
| 2005 | Wagner JE, Thompson JS, Carter SL, Kernan NA. Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): A multi-centre, randomised phase II-III trial Lancet. 366: 733-741. PMID 16125590 DOI: 10.1016/S0140-6736(05)66996-6 | 0.325 | |||
| 2005 | Fraser CJ, Hirsch BA, Dayton V, Creer MH, Neglia JP, Wagner JE, Baker KS. First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation. Blood. 106: 4377-80. PMID 16118319 DOI: 10.1182/BLOOD-2005-06-2551 | 0.385 | |||
| 2005 | Wall DA, Carter SL, Kernan NA, Kapoor N, Kamani NR, Brochstein JA, Frangoul H, Goyal RK, Horan JT, Pietryga D, Wagner JE, Kurtzberg J. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 11: 637-46. PMID 16041314 DOI: 10.1016/j.bbmt.2005.05.003 | 0.302 | |||
| 2005 | McCullough J, McKenna D, Kadidlo D, Schierman T, Wagner J. Issues in the quality of umbilical cord blood stem cells for transplantation. Transfusion. 45: 832-841. PMID 15934980 DOI: 10.1111/J.1537-2995.2005.04265.X | 0.302 | |||
| 2005 | Barker JN, Hough RE, van Burik JAH, DeFor TE, MacMillan ML, O'Brien MR, Wagner JE. Serious infections after unrelated donor transplantation in 136 children: Impact of stem cell source Biology of Blood and Marrow Transplantation. 11: 362-370. PMID 15846290 DOI: 10.1016/j.bbmt.2005.02.004 | 0.319 | |||
| 2005 | Cornetta K, Laughlin M, Carter S, Wall D, Weinthal J, Delaney C, Wagner J, Sweetman R, McCarthy P, Chao N. Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT). Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 11: 149-60. PMID 15682076 DOI: 10.1016/J.Bbmt.2004.11.020 | 0.352 | |||
| 2005 | Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS, Verfaillie CM, Wagner JE. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 105: 1343-7. PMID 15466923 DOI: 10.1182/Blood-2004-07-2717 | 0.374 | |||
| 2005 | Alsweedan SA, Wagner JE, Tan Y, DeFor TE, MacMillan ML. Prognostic Factors in Patients with Fanconi Anemia (FA) after Alternate Donor (AD) Hematopoietic Cell Transplantation (HCT). Blood. 106: 564-564. DOI: 10.1182/BLOOD.V106.11.564.564 | 0.327 | |||
| 2005 | Brunstein CG, Barker JN, DeFor TE, French K, Weisdorf DJ, Wagner JE. Non-Myeloablative (NMA) Umbilical Cord Blood Transplantation (UCBT): Promising Disease-Free Survival in 95 Consecutive Patients. Blood. 106: 559-559. DOI: 10.1182/BLOOD.V106.11.559.559 | 0.33 | |||
| 2005 | Orchard PJ, Tolar J, Basso L, Brunstein C, Tomblyn M, Baker S, Blazar B, Wagner J, Miller JS. Immunotherapy of EBV Post Solid Organ Transplantation Lymphoproliferative Disease with Genetically Engineered Haploidentical T Cells. Blood. 106: 5541-5541. DOI: 10.1182/Blood.V106.11.5541.5541 | 0.362 | |||
| 2005 | Fraser CJ, Wagner JE, MacMillan ML. Hematopoietic Stem Cell Transplantation (HSCT) as Curative Therapy for Fanconi Anemia (FA) Patients with Acute Leukemia or Advanced Myelodysplasia (MDS). Blood. 106: 5464-5464. DOI: 10.1182/BLOOD.V106.11.5464.5464 | 0.326 | |||
| 2005 | Eapen M, Haagenson M, Logan B, Confer D, Horowitz M, Wagner J, Weisdorf D, Anasetti C. Use of Peripheral Blood Grafts Is Associated with Increased Acute and Chronic Graft-Versus-Host Disease without Improved Survival after Unrelated Donor Transplantation. Blood. 106: 443-443. DOI: 10.1182/Blood.V106.11.443.443 | 0.371 | |||
| 2005 | Brunstein CG, Weisdorf DJ, DeFor T, Tolar J, Wagner JE. Increased Risk of Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder (EBV-PTLD) after Anti-Thymocyte Globulin (ATG) Non-Myeloablative (NMA) Conditioning for Umbilical Cord Blood Transplantation (UCBT). Blood. 106: 3235-3235. DOI: 10.1182/BLOOD.V106.11.3235.3235 | 0.311 | |||
| 2005 | Krishnamurti L, Wu C, Baker KS, Wagner JE. Matched Sibling Donor Hematopoietic Cell Transplantation for Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen Can Lead To Stable Long Term Engraftment. Blood. 106: 3172-3172. DOI: 10.1182/BLOOD.V106.11.3172.3172 | 0.319 | |||
| 2005 | Verneris MR, Brunstein C, DeFor TE, Barker J, Weisdorf DJ, Blazar BR, Miller JS, Wagner JE. Risk of Relapse (REL) after Umbilical Cord Blood Transplantation (UCBT) in Patients with Acute Leukemia: Marked Reduction in Recipients of Two Units. Blood. 106: 305-305. DOI: 10.1182/Blood.V106.11.305.305 | 0.341 | |||
| 2005 | Rubinstein P, Eapen M, Stevens C, Kurtzberg J, Scaradavou A, Klein J, Horowitz M, Wagner J. Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT) in Children with Acute Leukemia: Risks and Benefits of Umbilical Cord Blood (CB) vs. Bone Marrow (BM). Blood. 106: 302-302. DOI: 10.1182/Blood.V106.11.302.302 | 0.324 | |||
| 2005 | Barker JN, Weisdorf DJ, DeFor TE, Brunstein CG, Wagner JE. Umbilical Cord Blood (UCB) Transplantation after Non-Myeloablative (NMA) Conditioning for Advanced Follicular Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia: Low Transplant-Related Mortality and High Progression-Free Survival. Blood. 106: 2900-2900. DOI: 10.1182/BLOOD.V106.11.2900.2900 | 0.385 | |||
| 2005 | Harker-Murray P, Tolar J, Tan Y, MacMillan ML, Wagner J, Orchard PJ. Hematopoietic Cell Transplantation as Therapy for Pediatric Patients with Isolated CNS Relapse. Blood. 106: 2745-2745. DOI: 10.1182/BLOOD.V106.11.2745.2745 | 0.369 | |||
| 2005 | Kumar P, Defor TE, Brunstein C, Barker J, Wagner JE, Weisdorf DJ, Miller JS, McGlave P, Slungaard A, Arora M, Tomblyn M, Burns LJ. Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Treatment of Acute Lymphocytic Leukemia (ALL) in 126 Adults: Impact of Donor Source on Leukemia Free Survival (LFS). Blood. 106: 2064-2064. DOI: 10.1182/BLOOD.V106.11.2064.2064 | 0.322 | |||
| 2005 | Arora M, Nagaraj S, Wagner JE, Barker JN, Brunstein CG, Burns LJ, MacMillan ML, Miller JS, Weisdorf DJ. Chronic Graft Versus Host Disease (cGVHD) Following Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT): Higher Response Rate in Recipients of Unrelated Donor (URD) Umbilical Cord Blood (UCB). Blood. 106: 1814-1814. DOI: 10.1182/BLOOD.V106.11.1814.1814 | 0.345 | |||
| 2005 | Cooley S, McCullar V, Wangen R, Bergemann TL, Wagner JE, Weisdorf DJ, McGlave P, Miller JS. NK Cell KIR Reconstitution after Allogeneic Hematopoietic Cell Transplant (HCT) Is Affected by T Cell Number and Function. Blood. 106: 1406-1406. DOI: 10.1182/Blood.V106.11.1406.1406 | 0.335 | |||
| 2005 | Fraser CJ, Hirsch BA, Dayton V, Neglia JP, Wagner JE, Baker KS. First Report of Donor Cell Leukemia After Umbilical Cord Blood Transplantation Journal of Pediatric Hematology/Oncology. 27: 462. DOI: 10.1097/01.MPH.0000188545.86147.93 | 0.372 | |||
| 2005 | Kurtzberg J, Martin P, Carter S, Kernan N, Sahdev I, Wall D, Pietryga D, Wagner J. 20. Unrelated cord blood transplantation in pediatric patients with non-malignant diseases Biology of Blood and Marrow Transplantation. 11: 935-936. DOI: 10.1016/j.bbmt.2005.08.018 | 0.335 | |||
| 2005 | Wagner J, Brunstein C, Barker J. 7. Double umbilical cord blood transplantation Biology of Blood and Marrow Transplantation. 11: 930. DOI: 10.1016/J.BBMT.2005.08.006 | 0.333 | |||
| 2005 | Barker J, Wagner J. 6. Umbilical cord blood (UCB) transplantation for indolent lymphoid malignancies Biology of Blood and Marrow Transplantation. 11: 929-930. DOI: 10.1016/J.BBMT.2005.08.005 | 0.336 | |||
| 2005 | Kurtzberg J, Carter S, Sahdev I, Wall D, Pietryga D, Wagner J, Kernan N. Results of the cord blood transplantation study (COBLT): Clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with inborn errors of metabolism Biology of Blood and Marrow Transplantation. 11: 82. DOI: 10.1016/J.BBMT.2004.12.242 | 0.339 | |||
| 2005 | MacMillan M, Auerbach A, Champagne M, DeFor T, Slungaard A, Weisdorf D, Wagner J. Absence of prior infections is strongest predictor for survival after alternate donor hematopoietic cell transplantation in patients with Fanconi anemia Biology of Blood and Marrow Transplantation. 11: 33. DOI: 10.1016/j.bbmt.2004.12.095 | 0.34 | |||
| 2005 | Krishnamurti L, Wu C, Baker S, Yeager A, Wagner J. Stable long term engraftment and amelioration of clinical phenotype following hematopoietic stem cell transplantation from a matched sibling donor for sickle cell disease using a reduced intensity conditioning regimen Biology of Blood and Marrow Transplantation. 11: 28. DOI: 10.1016/J.BBMT.2004.12.080 | 0.328 | |||
| 2004 | Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. The New England Journal of Medicine. 351: 2265-75. PMID 15564543 DOI: 10.1056/NEJMoa041276 | 0.305 | |||
| 2004 | Eapen M, Horowitz MM, Klein JP, Champlin RE, Loberiza FR, Ringdén O, Wagner JE. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 4872-80. PMID 15520055 DOI: 10.1200/Jco.2004.02.189 | 0.365 | |||
| 2004 | Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringdén O, Bredeson CN, Martino R, Gale RP, Cairo MS, et al. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplantation. 34: 721-7. PMID 15322568 DOI: 10.1038/Sj.Bmt.1704645 | 0.36 | |||
| 2004 | Kumar AR, Wagner JE, Auerbach AD, Coad JE, Dietz CA, Schwarzenberg SJ, MacMillan ML. Fatal hemorrhage from androgen-related hepatic adenoma after hematopoietic cell transplantation. Journal of Pediatric Hematology/Oncology. 26: 16-8. PMID 14707705 | 0.303 | |||
| 2004 | Grewal SS, Kahn JP, MacMillan ML, Ramsay NK, Wagner JE. Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis. Blood. 103: 1147-51. PMID 14504102 DOI: 10.1182/blood-2003-02-0587 | 0.383 | |||
| 2004 | Wall D, Wagner J, Laughlin M, Ballen K, Staba S, Chan KW, McGaha O, Logan B, Klein J, Arora M. Higher Cell Dose and CD34+ Content Improves Engraftment Following Unrelated Donor Cord Blood Transplantation (CBT): A Report of the National Marrow Donor Program (NMDP) Cord Blood (CB) Experience. Blood. 104: 975-975. DOI: 10.1182/Blood.V104.11.975.975 | 0.356 | |||
| 2004 | Barker JN, Weisdorf DJ, Defor TE, Wagner JE. Double Unit Myeloablative Umbilical Cord Blood (UCB) Transplantation in Adults & Adolescents: High Incidence of Engraftment and Low Transplant-Related Mortality. Blood. 104: 826-826. DOI: 10.1182/BLOOD.V104.11.826.826 | 0.306 | |||
| 2004 | Barker JN, Weisdorf DJ, Defor TE, Wagner JE. Non-Myeloablative Umbilical Cord Blood Transplantation (UCBT): Low Transplant-Related Mortality in 59 High-Risk Adults. Blood. 104: 825-825. DOI: 10.1182/BLOOD.V104.11.825.825 | 0.318 | |||
| 2004 | Wagner JE, Eapen M, Harris RE, MacMillan ML, Auerbach AD. Unrelated Donor Transplantation for Fanconi Anemia: Analysis of Prognostic Factors Impacting Engraftment and Survival. Blood. 104: 824-824. DOI: 10.1182/blood.v104.11.824.824 | 0.397 | |||
| 2004 | Kurtzberg J, Creer M, Halet M, Welte K, Wagner JE, Boo M, Confer DL, Chell J. Establishment of the NMDP Cord Blood Banking Network. Blood. 104: 5190-5190. DOI: 10.1182/BLOOD.V104.11.5190.5190 | 0.373 | |||
| 2004 | Arora M, Wagner JE, Barker JN, Miller JS, Burns LJ, MacMillan ML, Blazar BR, Defor TE, Weisdorf DJ. Acute Graft-Versus-Host Disease: Clinical Presentation and Response to Therapy Following Umbilical Cord Blood Transplant. Blood. 104: 2148-2148. DOI: 10.1182/Blood.V104.11.2148.2148 | 0.383 | |||
| 2004 | Gluckman E, Rocha V, Ionescu I, Pasquini R, Harris R, Wagner J, Kurtzberg J, Duval M, Darbyshire P, Locatelli F, Fernandez M. Results of Unrelated Cord Blood Transplants in Fanconi Anemia. Blood. 104: 2145-2145. DOI: 10.1182/blood.v104.11.2145.2145 | 0.395 | |||
| 2004 | Markova M, Barker JN, Wagner JE, Miller JS, Arora M, Burns LJ, MacMillan ML, Repka T, Blazar BR, Weisdorf DJ. Fludarabine Is Superior to Cladribine When Added to Busulfan and Low Dose TBI as Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation (HCT): A Prospective Randomized Trial. Blood. 104: 1825-1825. DOI: 10.1182/Blood.V104.11.1825.1825 | 0.309 | |||
| 2004 | Flynn C, Barker JN, Miller JS, Wagner JE, DeFor T, Blazar BR, Burns LJ, MacMillan ML, Arora M, Weisdorf D. Reduced Intensity Compared to High Dose Conditioning for Allotransplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Comparative Clinical Analysis. Blood. 104: 1817-1817. DOI: 10.1182/blood.v104.11.1817.1817 | 0.351 | |||
| 2004 | Wagner J, Barker J. Umbilical cord blood transplantation: Novel approaches toward improving engraftment Biology of Blood and Marrow Transplantation. 10: 733. DOI: 10.1016/J.BBMT.2004.06.012 | 0.319 | |||
| 2003 | Wolf SM, Kahn JP, Wagner JE. Using preimplantation genetic diagnosis to create a stem cell donor: Issues, guidelines & limits Journal of Law, Medicine and Ethics. 31: 327-339. PMID 14626542 | 0.352 | |||
| 2003 | Barker JN, Wagner JE. Umbilical cord blood transplantation: Current practice and future innovations Critical Reviews in Oncology/Hematology. 48: 35-43. PMID 14585482 DOI: 10.1016/S1040-8428(03)00092-1 | 0.372 | |||
| 2003 | Barker JN, Wagner JE. Umbilical-cord blood transplantation for the treatment of cancer Nature Reviews Cancer. 3: 526-532. PMID 12835672 DOI: 10.1038/nrc1125 | 0.358 | |||
| 2003 | Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood. 102: 1915-9. PMID 12738676 DOI: 10.1182/Blood-2002-11-3337 | 0.361 | |||
| 2003 | Anderson D, DeFor T, Burns L, McGlave P, Miller J, Wagner J, Weisdorf D. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 9: 52-9. PMID 12533742 DOI: 10.1053/BBMT.2003.50000 | 0.384 | |||
| 2003 | Grewal SS, Barker JN, Davies SM, Wagner JE. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood. 101: 4233-44. PMID 12522002 DOI: 10.1182/BLOOD-2002-08-2510 | 0.382 | |||
| 2003 | Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 8: 257-60. PMID 12064362 DOI: 10.1053/BBMT.2002.V8.PM12064362 | 0.387 | |||
| 2003 | Wall D, Carter S, Kapoor N, Kamani N, Kernan N, Jensen L, Brochstein J, Frangoul H, Goyal R, Horan J, Pietryga D, Wagner J, Kurtzberg J. 53 Busulfan/melphalan/ATG (BU/MEL/ATG) as a preparative regimen for unrelated donor cord blood transplantation (UCBT): The coblt experience Biology of Blood and Marrow Transplantation. 9: 81. DOI: 10.1016/S1083-8791(03)80054-X | 0.348 | |||
| 2002 | Engelfriet CP, Reesink HW, Wagner JE, Kögler G, Rocha V, Wernet P, Lecchi L, Lazzari L, Ratti I, Giovanelli S, Poli F, Rebulla P, Beguin Y, Baudoux E, Navarrete C, et al. International forum. Use of umbilical cord blood progenitor cells as an alternative for bone marrow transplantation. Vox Sanguinis. 83: 172-87. PMID 12201852 DOI: 10.1046/J.1423-0410.2002.00197.X | 0.311 | |||
| 2002 | Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan ML, Orchard PJ, Peters C, Weisdorf DJ, Ramsay NK, Davies SM. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 100: 1611-8. PMID 12176879 DOI: 10.1182/Blood-2002-01-0294 | 0.363 | |||
| 2002 | MacMillan ML, Weisdorf DJ, Wagner JE, DeFor TE, Burns LJ, Ramsay NK, Davies SM, Blazar BR. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 8: 387-94. PMID 12171485 DOI: 10.1053/Bbmt.2002.V8.Pm12171485 | 0.324 | |||
| 2002 | Baker KS, Wagner JE. Novel conditioning regimens and nonmyeloablative stem cell transplants Current Opinion in Pediatrics. 14: 17-22. PMID 11880729 DOI: 10.1097/00008480-200202000-00004 | 0.371 | |||
| 2002 | Barker JN, Wagner JE. Umbilical cord blood transplantation: Current state of the art Current Opinion in Oncology. 14: 160-164. PMID 11880705 DOI: 10.1097/00001622-200203000-00004 | 0.382 | |||
| 2002 | Smith FO, King R, Nelson G, Wagner JE, Robertson KA, Sanders JE, Bunin N, Emaunel PD, Davies SM. Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukaemia. British Journal of Haematology. 116: 716-24. PMID 11849238 DOI: 10.1046/j.0007-1048.2001.03333.x | 0.35 | |||
| 2001 | Friedman TM, Varadi G, Hopely DD, Filicko J, Wagner J, Ferber A, Martinez J, Brunner J, Grosso D, McGuire L, Korngold R, Flomenberg N. Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches Biology of Blood and Marrow Transplantation. 7: 656-664. PMID 11787528 DOI: 10.1053/BBMT.2001.V7.PM11787528 | 0.333 | |||
| 2001 | Ballen K, Broxmeyer HE, McCullough J, Piaciabello W, Rebulla P, Verfaillie CM, Wagner JE. Current status of cord blood banking and transplantation in the United States and Europe Biology of Blood and Marrow Transplantation. 7: 635-645. PMID 11787526 DOI: 10.1053/Bbmt.2001.V7.Pm11787526 | 0.346 | |||
| 2001 | Barker JN, Martin PL, Coad JE, DeFor T, Trigg ME, Kurtzberg J, Weisdorf DJ, Wagner J. Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 7: 395-9. PMID 11529490 DOI: 10.1053/BBMT.2001.V7.PM11529490 | 0.39 | |||
| 2001 | Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors [6] New England Journal of Medicine. 344: 1870-1871. PMID 11407361 DOI: 10.1056/NEJM200106143442417 | 0.354 | |||
| 2001 | Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, Gerson SL, Lazarus HM, Cairo M, Stevens CE, Rubinstein P, Kurtzberg J. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. The New England Journal of Medicine. 344: 1815-22. PMID 11407342 DOI: 10.1056/NEJM200106143442402 | 0.333 | |||
| 2001 | Barker JN, Davies SM, DeFor T, Ramsay NK, Weisdorf DJ, Wagner JE. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood. 97: 2957-61. PMID 11342417 DOI: 10.1182/BLOOD.V97.10.2957 | 0.401 | |||
| 2001 | Davies SM, DeFor TE, McGlave PB, Miller JS, Verfaillie CM, Wagner JE, Weisdorf DJ. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors American Journal of Medicine. 110: 339-346. PMID 11286947 DOI: 10.1016/S0002-9343(01)00629-5 | 0.357 | |||
| 2001 | Weinberg K, Blazar BR, Wagner JE, Agura E, Hill BJ, Smogorzewska M, Koup RA, Betts MR, Collins RH, Douek DC. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation Blood. 97: 1458-1466. PMID 11222394 DOI: 10.1182/Blood.V97.5.1458 | 0.338 | |||
| 2000 | Lickliter JD, McGlave PB, DeFor TE, Miller JS, Ramsay NK, Verfaillie C, Burns LJ, Wagner JE, Eastlund T, Dusenbery K, Weisdorf DJ. Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation. Bone Marrow Transplantation. 26: 723-728. PMID 11042652 DOI: 10.1038/Sj.Bmt.1702606 | 0.334 | |||
| 2000 | Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. The New England Journal of Medicine. 342: 1846-54. PMID 10861319 DOI: 10.1056/Nejm200006223422501 | 0.348 | |||
| 2000 | MacMillan ML, Auerbach AD, Davies SM, Defor TE, Gillio A, Giller R, Harris R, Cairo M, Dusenbery K, Hirsch B, Ramsay NK, Weisdorf DJ, Wagner JE. Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial. British Journal of Haematology. 109: 121-9. PMID 10848791 DOI: 10.1046/j.1365-2141.2000.01955.x | 0.368 | |||
| 2000 | Krishnamurti L, Blazar BR, Grossi M, Abel S, Vichinsky E, Lubin BH, Wagner JE. Treatment of sickle cell disease (SCD) by an allogeneic hematopoietic stem cell transplantation (HSCT) using a non-myeloablative preparative regimen Journal of Pediatric Hematology Oncology. 22: 387. DOI: 10.1097/00043426-200007000-00093 | 0.325 | |||
| 2000 | Krivit W, Peters C, Shapiro EG, Lockman L, Ziegler R, Wagner JE, Ramsay NK. A review of outcomes in 180 patients treated by hematopoietic cell transplantation (HCT) for lysosomal and peroxisomal diseases in the past 18 years at the University of Minnesota Journal of Pediatric Hematology/Oncology. 22: 369. DOI: 10.1097/00043426-200007000-00031 | 0.312 | |||
| 2000 | Engelfriet C, Vanderson R, Wagner J, Sobocinski K. Graft versus Host Disease in Children Who Have Received a Cord Blood or Bone Marrow Transplant from HLA-Identical Siblings Vox Sanguinis. 79: 265-265. DOI: 10.1046/j.1423-0410.2000.79402652.x | 0.307 | |||
| 1999 | Gross TG, Steinbuch M, DeFor T, Shapiro RS, McGlave P, Ramsay NK, Wagner JE, Filipovich AH. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transplantation. 23: 251-8. PMID 10084256 DOI: 10.1038/sj.bmt.1701554 | 0.367 | |||
| 1998 | Fraser JK, Cairo MS, Wagner EL, McCurdy PR, Baxter-Lowe LA, Carter SL, Kernan NA, Lill MC, Slone V, Wagner JE, Wallas CH, Kurtzberg J. Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. Journal of Hematotherapy. 7: 521-61. PMID 9919946 DOI: 10.1089/SCD.1.1998.7.521 | 0.519 | |||
| 1998 | Wagner JE, Kurtzberg J. Banking and transplantation of unrelated donor umbilical cord blood: Status of the national heart, lung, and blood institute-sponsored trial Transfusion. 38: 807-809. PMID 9738618 DOI: 10.1046/J.1537-2995.1998.38998408998.X | 0.377 | |||
| 1998 | Krivit W, Shapiro EG, Peters C, Wagner JE, Cornu G, Kurtzberg J, Wenger DA, Kolodny EH, Vanier MT, Loes DJ, Dusenbery K, Lockman LA. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. The New England Journal of Medicine. 338: 1119-26. PMID 9545360 DOI: 10.1056/Nejm199804163381605 | 0.343 | |||
| 1998 | Peters C, Shapiro EG, Anderson J, Henslee-Downey PJ, Klemperer MR, Cowan MJ, Saunders EF, deAlarcon PA, Twist C, Nachman JB, Hale GA, Harris RE, Rozans MK, Kurtzberg J, Grayson GH, ... ... Wagner JE, et al. Hurler Syndrome: II. Outcome of HLA-Genotypically Identical Sibling and HLA-Haploidentical Related Donor Bone Marrow Transplantation in Fifty-Four Children Blood. 91: 2601-2608. DOI: 10.1182/Blood.V91.7.2601.2601_2601_2608 | 0.312 | |||
| 1998 | Wagner JE. Use of Cord Blood Progenitor Cells as an Alternative for Bone Marrow Transplantation Vox Sanguinis. 75: 158-160. DOI: 10.1046/j.1423-0410.1998.75201562.x | 0.308 | |||
| 1997 | Davies SM, Wagner JE, Defor T, Blazar BR, Katsanis E, Kersey JH, Orchard PJ, Mcglave PB, Weisdorf DJ, Ramsay NKC. Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasia British Journal of Haematology. 96: 749-756. PMID 9074418 DOI: 10.1046/J.1365-2141.1997.D01-2087.X | 0.342 | |||
| 1997 | Wagner JE. Allogeneic umbilical cord blood transplantation Cancer Treatment and Research. 77: 187-216. PMID 9071504 DOI: 10.1007/978-1-4615-6349-5_9 | 0.37 | |||
| 1997 | Davies SM, Wagner JE, Weisdorf DJ, Shu XO, Blazar BR, Enright H, McGlave PB, Ramsay NK. Unrelated donor bone marrow transplantation for hematological malignancies-current status. Leukemia & Lymphoma. 23: 221-6. PMID 9031102 DOI: 10.3109/10428199609054824 | 0.389 | |||
| 1997 | Cairo MS, Wagner JE. Placental and/or Umbilical Cord Blood: An Alternative Source of Hematopoietic Stem Cells for Transplantation Blood. 90: 4665-4678. DOI: 10.1182/BLOOD.V90.12.4665.4665_4665_4678 | 0.338 | |||
| 1996 | Wagner J, Rosenthal J, Sweetman R, Shu X, Davies S, Ramsay N, McGlave P, Sender L, Cairo M. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease Blood. 88: 795-802. DOI: 10.1182/BLOOD.V88.3.795.BLOODJOURNAL883795 | 0.399 | |||
| 1995 | Wagner JE. Umbilical cord blood transplantation. Transfusion. 35: 619-21. PMID 7631398 DOI: 10.1046/J.1537-2995.1995.35895357889.X | 0.362 | |||
| 1995 | Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet (London, England). 346: 214-9. PMID 7616801 DOI: 10.1016/S0140-6736(95)91268-1 | 0.386 | |||
| 1995 | Wagner JE. Umbilical cord blood stem cell transplantation. Cancer Treatment and Research. 76: 195-213. PMID 7577335 DOI: 10.1007/978-1-4615-2013-9_8 | 0.349 | |||
| 1993 | Wagner JE. Umbilical cord blood stem cell transplantation Journal of Pediatric Hematology/Oncology. 15: 169-174. PMID 8098918 DOI: 10.1097/00043426-199305000-00004 | 0.331 | |||
| 1993 | Wagner JE. Umbilical cord and placental blood transplantation: Analysis of the clinical results Journal of Hematotherapy. 2: 265-268. PMID 7921988 DOI: 10.1089/SCD.1.1993.2.265 | 0.412 | |||
| 1993 | Wagner JE. Umbilical cord blood stem cell transplantation: Current status and future prospects (1992) Journal of Hematotherapy. 2: 225-228. PMID 7921979 DOI: 10.1089/SCD.1.1993.2.225 | 0.342 | |||
| 1992 | Wagner JE, Zahurak M, Piantadosi S, Geller RB, Vogelsang GB, Wingard JR, Saral R, Griffin C, Shah N, Zehnbauer BA, Ambinder R, Burns W, Jones R, May WS, Rowley S, et al. Bone marrow transplantation of chronic myelogenous leukemia in chronic phaseevaluation of risks and benefits Journal of Clinical Oncology. 10: 779-789. PMID 1569450 DOI: 10.1200/JCO.1992.10.5.779 | 0.314 | |||
| 1992 | Wagner J, Broxmeyer H, Byrd R, Zehnbauer B, Schmeckpeper B, Shah N, Griffin C, Emanuel P, Zuckerman K, Cooper S. Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment [see comments] Blood. 79: 1874-1881. DOI: 10.1182/blood.v79.7.1874.bloodjournal7971874 | 0.349 | |||
| 1992 | Wagner J, Broxmeyer H, Byrd R, Zehnbauer B, Schmeckpeper B, Shah N, Griffin C, Emanuel P, Zuckerman K, Cooper S. Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment [see comments] Blood. 79: 1874-1881. DOI: 10.1182/BLOOD.V79.7.1874.1874 | 0.349 | |||
| 1991 | Zehnbauer B, Griffin C, Santos G, Wagner J. Comparison of molecular and cytogenetic methods in the evaluation of engraftment following allogeneic bone marrow transplantation Cancer Genetics and Cytogenetics. 55: 181-190. PMID 1682032 DOI: 10.1016/0165-4608(91)90076-7 | 0.316 | |||
| 1990 | Wagner J, Santos G, Noga S, Rowley S, Davis J, Vogelsang G, Farmer E, Zehnbauer B, Saral R, Donnenberg A. Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial Blood. 75: 1370-1377. DOI: 10.1182/BLOOD.V75.6.1370.1370 | 0.331 | |||
| Show low-probability matches. | |||||